Distinct	O
DNase-I	B-DNA
hypersensitive	I-DNA
sites	I-DNA
are	O
associated	O
with	O
TAL-1	B-protein
transcription	O
in	O
erythroid	B-cell_line
and	I-cell_line
T-cell	I-cell_line
lines	I-cell_line
.	O

The	O
tal-1	B-DNA
gene	I-DNA
,	O
frequently	O
activated	O
in	O
human	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
(	O
T-ALL	O
)	O
,	O
is	O
expressed	O
in	O
the	O
erythroid	B-cell_type
,	I-cell_type
megakaryocytic	I-cell_type
,	I-cell_type
and	I-cell_type
mast	I-cell_type
cell	I-cell_type
lineages	I-cell_type
during	O
normal	O
hematopoiesis	O
.	O

To	O
gain	O
further	O
insight	O
into	O
the	O
molecular	O
mechanisms	O
that	O
control	O
tal-1	B-DNA
expression	O
,	O
we	O
investigated	O
tal-1	B-DNA
chromatin	O
structure	O
in	O
erythroid/megakaryocytic	B-cell_line
cell	I-cell_line
lines	I-cell_line
and	O
in	O
T-cell	B-cell_line
lines	I-cell_line
either	O
with	O
or	O
without	O
tal-1	B-DNA
rearrangements	I-DNA
.	O

Tal-1	O
transcription	O
was	O
shown	O
to	O
be	O
monoallelic	O
in	O
Jurkat	B-cell_line
,	O
a	O
T-cell	O
line	O
that	O
expresses	O
tal-1	B-DNA
in	O
the	O
absence	O
of	O
apparent	O
genomic	O
alteration	O
of	O
the	O
locus	O
.	O

Methylation	O
studies	O
indicated	O
that	O
the	O
tal-15	B-DNA
'	I-DNA
GC-rich	I-DNA
region	I-DNA
behaves	O
like	O
a	O
CpG	B-DNA
island	I-DNA
,	O
hypomethylated	O
in	O
normal	B-cell_type
cells	I-cell_type
,	O
and	O
methylated	O
de	O
novo	O
on	O
transcriptionally	B-DNA
inactive	I-DNA
alleles	I-DNA
in	O
established	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Five	O
major	O
DNase-I	B-DNA
hypersensitive	I-DNA
sites	I-DNA
(	O
HS	B-DNA
)	O
were	O
mapped	O
in	O
the	O
tal-1	B-DNA
locus	O
.	O

HS	B-DNA
I	I-DNA
,	I-DNA
IV	I-DNA
,	I-DNA
and	I-DNA
V	I-DNA
were	O
exclusively	O
observed	O
in	O
the	O
erythroid/megakaryocytic	B-cell_line
cell	I-cell_line
lines	I-cell_line
that	O
express	O
tal-1	B-DNA
from	O
the	O
promoters	B-DNA
1a	I-DNA
and	I-DNA
1b	I-DNA
.	O

HS	B-DNA
II	I-DNA
was	O
weak	O
in	O
hematopoietic	B-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
absent	O
in	O
Hela	B-cell_line
,	O
and	O
greatly	O
enhanced	O
in	O
Jurkat	B-cell_line
,	O
suggesting	O
that	O
this	O
region	O
might	O
be	O
implicated	O
in	O
the	O
cis-activation	O
of	O
tal-1	B-DNA
promoter	I-DNA
1b	I-DNA
in	O
this	O
cell	O
line	O
.	O

HS	B-DNA
III	I-DNA
was	O
weak	O
in	O
HEL	B-cell_line
and	O
Jurkat	B-cell_line
,	O
and	O
greatly	O
enhanced	O
in	O
DU528	B-cell_line
,	O
a	O
T-cell	B-cell_line
line	I-cell_line
that	O
bears	O
a	B-DNA
t	I-DNA
(	I-DNA
1	I-DNA
;	I-DNA
14	I-DNA
)	I-DNA
and	O
initiates	O
tal-1	B-DNA
transcription	O
within	O
exon	B-DNA
4	I-DNA
.	O

These	O
results	O
suggest	O
that	O
distinct	O
regulatory	B-DNA
elements	I-DNA
are	O
associated	O
with	O
the	O
use	O
of	O
the	O
different	O
tal-1	B-DNA
promoters	I-DNA
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Distinct	NULL
DNase-I	NULL
Hypersensitive	NULL
Sites	NULL
Are	NULL
Associated	NULL
With	NULL
TAL-1	NULL
Transcription	NULL
in	NULL
Erythroid	NULL
and	NULL
T-Cell	NULL
Lines	NULL
By	NULL
Karen	NULL
Leroy-Viard	NULL
,	NULL
Marie-Antoinette	NULL
Vinit	NULL
,	NULL
Nathalie	NULL
Lecointe	NULL
,	NULL
Daniéle	NULL
Mathieu-Mahul	NULL
,	NULL
and	NULL
Paul-Henri	NULL
Roméo	NULL
The	NULL
tal-1	NULL
gene	NULL
,	NULL
frequently	NULL
activated	NULL
in	NULL
human	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
T-ALL	NULL
)	NULL
,	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
erythroid	NULL
,	NULL
megakaryocytic	NULL
,	NULL
and	NULL
mast	NULL
cell	NULL
lineages	NULL
during	NULL
nor-mai	NULL
hematopoiesis	NULL
.	NULL

To	NULL
gain	NULL
further	NULL
insight	NULL
into	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
control	NULL
tal-1	NULL
expression	NULL
,	NULL
we	NULL
investigated	NULL
tal-1	NULL
chromatin	NULL
structure	NULL
in	NULL
erythroid/megakaryocytic	NULL
cell	NULL
lines	NULL
and	NULL
in	NULL
T-cell	NULL
lines	NULL
either	NULL
with	NULL
or	NULL
without	NULL
tal-1	NULL
rearrangements	NULL
.	NULL

Tal-1	NULL
transcription	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
monoallelic	NULL
in	NULL
Jurkat	NULL
,	NULL
a	NULL
T-cell	NULL
line	NULL
that	NULL
expresses	NULL
tal-1	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
apparent	NULL
genomic	NULL
alteration	NULL
of	NULL
the	NULL
locus	NULL
.	NULL

Methylation	NULL
studies	NULL
indicated	NULL
that	NULL
the	NULL
tal-1	NULL
5	NULL
'	NULL
GC-rich	NULL
region	NULL
behaves	NULL
like	NULL
a	NULL
CpG	NULL
island	NULL
,	NULL
hypomethylated	NULL
in	NULL
normal	NULL
cells	NULL
,	NULL
and	NULL
methylated	NULL
de	NULL
novo	NULL
on	NULL
transcriptionally	NULL
inactive	NULL
alleles	NULL
HE	NULL
TAL-1	NULL
GENE	NULL
(	NULL
also	NULL
called	NULL
SCL	NULL
)	NULL
was	NULL
initially	NULL
identified	NULL
because	NULL
of	NULL
its	NULL
involvement	NULL
in	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocations	NULL
associated	NULL
with	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
T-ALL	NULL
)	NULL
.	NULL
'	NULL

''	NULL
The	NULL
tal-1	NULL
protein	NULL
possesses	NULL
a	NULL
basic-helix-loop-helix	NULL
domain	NULL
,	NULL
and	NULL
therefore	NULL
belongs	NULL
to	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
and	NULL
associated	NULL
with	NULL
leukemogenesis	NULL
.	NULL

*	NULL
``	NULL
During	NULL
normal	NULL
hemato-poiesis	NULL
,	NULL
tal-1	NULL
gene	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
erythroid	NULL
,	NULL
megakaryocytic	NULL
,	NULL
and	NULL
mast	NULL
cell	NULL
lineages	NULL
.	NULL
``	NULL

In	NULL
leukemic	NULL
T	NULL
cells	NULL
,	NULL
its	NULL
expression	NULL
is	NULL
often	NULL
linked	NULL
to	NULL
chromosomal	NULL
rearrangements	NULL
.	NULL

These	NULL
rearrangements	NULL
are	NULL
the	NULL
most	NULL
frequent	NULL
chromosomal	NULL
abnormalities	NULL
associated	NULL
with	NULL
T-ALL	NULL
,	NULL
since	NULL
they	NULL
affect	NULL
approximately	NULL
30	NULL
%	NULL
of	NULL
patients	NULL
with	NULL
childhood	NULL
T-ALL	NULL
.	NULL

Furthermore	NULL
,	NULL
they	NULL
appear	NULL
to	NULL
be	NULL
highly	NULL
specific	NULL
of	NULL
this	NULL
disease	NULL
,	NULL
since	NULL
tal-1	NULL
rearrangements	NULL
have	NULL
not	NULL
been	NULL
observed	NULL
in	NULL
other	NULL
types	NULL
of	NULL
leukemias	NULL
or	NULL
lymphomas	NULL
,	NULL
except	NULL
in	NULL
one	NULL
case	NULL
of	NULL
B-ALL	NULL
.	NULL

*	NULL
``	NULL
The	NULL
most	NULL
common	NULL
tal-1	NULL
rearrangement	NULL
(	NULL
12	NULL
%	NULL
to	NULL
25	NULL
%	NULL
of	NULL
T-ALL	NULL
patients	NULL
)	NULL
is	NULL
a	NULL
submicroscopic	NULL
90-kb	NULL
deletion	NULL
(	NULL
tal-1	NULL
d	NULL
)	NULL
juxtaposing	NULL
the	NULL
first	NULL
exons	NULL
of	NULL
the	NULL
SIL	NULL
gene	NULL
to	NULL
the	NULL
5	NULL
noncoding	NULL
part	NULL
of	NULL
tal-1	NULL
transcription	NULL
unit	NULL
.	NULL

``	NULL
``	NULL
``	NULL
'*	NULL
``	NULL
An	NULL
additional	NULL
3	NULL
%	NULL
of	NULL
T-ALL	NULL
patients	NULL
present	NULL
a	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p32	NULL
;	NULL
q11	NULL
)	NULL
translocation	NULL
.	NULL
``	NULL

In	NULL
most	NULL
of	NULL
the	NULL
cases	NULL
,	NULL
the	NULL
recombination	NULL
implicates	NULL
1p32	NULL
breakpoints	NULL
clustered	NULL
within	NULL
a	NULL
1-kb	NULL
segment	NULL
flanking	NULL
tal-1	NULL
exon	NULL
3	NULL
,	NULL
and	NULL
14q11	NULL
breakpoints	NULL
in	NULL
the	NULL
TCR6	NULL
locus	NULL
.	NULL

These	NULL
translocations	NULL
result	NULL
in	NULL
the	NULL
positioning	NULL
of	NULL
the	NULL
D6	NULL
region	NULL
to	NULL
the	NULL
5	NULL
'	NULL
side	NULL
of	NULL
tal-1	NULL
coding	NULL
region	NULL
.	NULL
``	NULL

''	NULL
This	NULL
type	NULL
of	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
high	NULL
level	NULL
of	NULL
tal1	NULL
transcription	NULL
,	NULL
presumably	NULL
initiating	NULL
within	NULL
the	NULL
D6	NULL
region	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
in	NULL
rearrangements	NULL
affecting	NULL
the	NULL
5	NULL
``	NULL
part	NULL
of	NULL
tal-1	NULL
locus	NULL
,	NULL
the	NULL
transcription	NULL
initiation	NULL
is	NULL
clearly	NULL
driven	NULL
from	NULL
promoters	NULL
active	NULL
in	NULL
the	NULL
T-cell	NULL
lineage	NULL
and	NULL
brought	NULL
in	NULL
the	NULL
5	NULL
'	NULL
vicinity	NULL
of	NULL
tal-1	NULL
transcription	NULL
unit	NULL
.	NULL

This	NULL
mechanism	NULL
might	NULL
also	NULL
explain	NULL
the	NULL
recently	NULL
reported	NULL
case	NULL
of	NULL
a	NULL
T-ALL	NULL
that	NULL
displayed	NULL
a	NULL
translocation	NULL
t	NULL
(	NULL
1	NULL
;	NULL
3	NULL
)	NULL
(	NULL
p34	NULL
;	NULL
p21	NULL
)	NULL
involving	NULL
a	NULL
chromosome	NULL
1	NULL
breakpoint	NULL
located	NULL
10	NULL
kb	NULL
5	NULL
'	NULL
of	NULL
tal-1	NULL
first	NULL
exon	NULL
,	NULL
and	NULL
a	NULL
novel	NULL
transcription	NULL
unit	NULL
on	NULL
chromosome	NULL
3	NULL
,	NULL
active	NULL
in	NULL
the	NULL
T-cell	NULL
lineage	NULL
.	NULL
``	NULL

In	NULL
two	NULL
cases	NULL
of	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
that	NULL
affected	NULL
the	NULL
3	NULL
'	NULL
proximal	NULL
region	NULL
of	NULL
tal-1	NULL
locus	NULL
and	NULL
the	NULL
D6	NULL
region	NULL
,	NULL
tal1	NULL
transcription	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
initiated	NULL
within	NULL
tal-1	NULL
fourth	NULL
exon	NULL
.	NULL
``	NULL

More	NULL
distal	NULL
3	NULL
'	NULL
breakpoints	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
two	NULL
additional	NULL
cases	NULL
of	NULL
T-ALL	NULL
.	NULL

***	NULL
'	NULL
Although	NULL
the	NULL
consequences	NULL
of	NULL
these	NULL
distal	NULL
rearrangements	NULL
on	NULL
tal-	NULL
1	NULL
transcription	NULL
have	NULL
not	NULL
Blood	NULL
,	NULL
Vol	NULL
84	NULL
,	NULL
No	NULL
11	NULL
(	NULL
December	NULL
1	NULL
)	NULL
,	NULL
1994	NULL
:	NULL
pp	NULL
3819-3827	NULL
in	NULL
established	NULL
cell	NULL
lines	NULL
.	NULL

Five	NULL
major	NULL
DNase-l	NULL
hypersensitive	NULL
sites	NULL
(	NULL
HS	NULL
)	NULL
were	NULL
mapped	NULL
in	NULL
the	NULL
tal-1	NULL
locus	NULL
.	NULL

HS	NULL
I	NULL
,	NULL
IV	NULL
,	NULL
and	NULL
V	NULL
were	NULL
exclusively	NULL
observed	NULL
in	NULL
the	NULL
erythroid/megakaryocytic	NULL
cell	NULL
lines	NULL
that	NULL
express	NULL
tal-1	NULL
from	NULL
the	NULL
promoters	NULL
1a	NULL
and	NULL
1b	NULL
.	NULL

HS	NULL
II	NULL
was	NULL
weak	NULL
in	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
,	NULL
absent	NULL
in	NULL
Hela	NULL
,	NULL
and	NULL
greatly	NULL
enhanced	NULL
in	NULL
Jurkat	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
region	NULL
might	NULL
be	NULL
implicated	NULL
in	NULL
the	NULL
cis-activation	NULL
of	NULL
tal-1	NULL
promoter	NULL
1b	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
.	NULL

HS	NULL
H1	NULL
was	NULL
weak	NULL
in	NULL
HEL	NULL
and	NULL
Jurkat	NULL
,	NULL
and	NULL
greatly	NULL
enhanced	NULL
in	NULL
DUS528	NULL
,	NULL
a	NULL
T-cell	NULL
line	NULL
that	NULL
bears	NULL
a	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
and	NULL
initiates	NULL
tal-1	NULL
transcription	NULL
within	NULL
exon	NULL
4	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
distinct	NULL
regulatory	NULL
elements	NULL
are	NULL
associated	NULL
with	NULL
the	NULL
use	NULL
of	NULL
the	NULL
different	NULL
tal-1	NULL
promoters	NULL
.	NULL

©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

been	NULL
explored	NULL
,	NULL
they	NULL
suggest	NULL
that	NULL
tal-1	NULL
activation	NULL
might	NULL
be	NULL
mediated	NULL
by	NULL
long	NULL
range	NULL
cis-activating	NULL
mechanisms	NULL
.	NULL

These	NULL
3	NULL
'	NULL
alterations	NULL
of	NULL
tal-	NULL
1	NULL
locus	NULL
,	NULL
either	NULL
proximal	NULL
or	NULL
more	NULL
distal	NULL
,	NULL
raise	NULL
the	NULL
question	NULL
of	NULL
which	NULL
DNA	NULL
regions	NULL
within	NULL
the	NULL
tal-1	NULL
locus	NULL
mediate	NULL
the	NULL
transcriptional	NULL
response	NULL
to	NULL
the	NULL
T-lymphoid	NULL
regulatory	NULL
elements	NULL
translocated	NULL
on	NULL
chromosome	NULL
1	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
several	NULL
established	NULL
T-cell	NULL
lines	NULL
and	NULL
blasts	NULL
from	NULL
T-ALL	NULL
patients	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
tal-1	NULL
transcripts	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
apparent	NULL
tal-1	NULL
genomic	NULL
alter-ation	NULL
.	NULL
``	NULL

It	NULL
is	NULL
presently	NULL
unknown	NULL
whether	NULL
tal-1	NULL
transcription	NULL
in	NULL
such	NULL
leukemic	NULL
T	NULL
cells	NULL
reflects	NULL
an	NULL
activation	NULL
in	NULL
trans	NULL
of	NULL
both	NULL
alleles	NULL
or	NULL
a	NULL
cis	NULL
activation	NULL
of	NULL
a	NULL
single	NULL
allele	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
that	NULL
control	NULL
tal-1	NULL
expression	NULL
in	NULL
its	NULL
germline	NULL
configuration	NULL
(	NULL
ie	NULL
,	NULL
in	NULL
the	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
lineages	NULL
)	NULL
and	NULL
in	NULL
T-ALL	NULL
devoid	NULL
of	NULL
5	NULL
alterations	NULL
of	NULL
the	NULL
locus	NULL
are	NULL
so	NULL
far	NULL
poorly	NULL
understood	NULL
.	NULL

Two	NULL
promoters	NULL
,	NULL
la	NULL
and	NULL
1b	NULL
,	NULL
are	NULL
located	NULL
in	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
tal-1	NULL
gene	NULL
,	NULL
and	NULL
a	NULL
third	NULL
promoter	NULL
is	NULL
located	NULL
within	NULL
tal-1	NULL
fourth	NULL
exon	NULL
.	NULL

The	NULL
promoter	NULL
1a	NULL
is	NULL
active	NULL
only	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
lineages	NULL
,	NULL
whereas	NULL
the	NULL
promoter	NULL
1b	NULL
is	NULL
active	NULL
both	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
in	NULL
leukemic	NULL
T	NULL
cells	NULL
without	NULL
evident	NULL
genomic	NULL
alterations	NULL
of	NULL
tal-1	NULL
.	NULL
'	NULL

''	NULL
The	NULL
promoter	NULL
located	NULL
in	NULL
exon	NULL
4	NULL
is	NULL
active	NULL
in	NULL
leukemic	NULL
T	NULL
cells	NULL
either	NULL
with	NULL
or	NULL
without	NULL
obvious	NULL
alterations	NULL
of	NULL
the	NULL
locus	NULL
,	NULL
but	NULL
not	NULL
in	NULL
normal	NULL
bone	NULL
marrow	NULL
or	NULL
in	NULL
established	NULL
cell	NULL
lines	NULL
of	NULL
the	NULL
erythroid/megakaryocytic	NULL
lineages	NULL
.	NULL
``	NULL

Apart	NULL
from	NULL
the	NULL
three	NULL
promoters	NULL
mentioned	NULL
above	NULL
,	NULL
From	NULL
INSERM	NULL
U	NULL
91	NULL
,	NULL
Hopital	NULL
Henri	NULL
Mondor	NULL
,	NULL
Créteil	NULL
,	NULL
France	NULL
;	NULL
and	NULL
Institut	NULL
de	NULL
Génétique	NULL
Moléculaire	NULL
de	NULL
Montpellier	NULL
,	NULL
UMR	NULL
9942	NULL
,	NULL
CNRS	NULL
,	NULL
Montpellier	NULL
,	NULL
France	NULL
.	NULL

Submitted	NULL
May	NULL
31	NULL
,	NULL
1994	NULL
;	NULL
accepted	NULL
August	NULL
8	NULL
,	NULL
1994	NULL
.	NULL

Supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Ligue	NULL
Contre	NULL
le	NULL
Cancer	NULL
,	NULL
the	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
contre	NULL
le	NULL
Cancer	NULL
,	NULL
and	NULL
the	NULL
Fondation	NULL
pour	NULL
la	NULL
Recherche	NULL
Medicale	NULL
(	NULL
K.L.-V.	NULL
)	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Paul-Henri	NULL
Roméo	NULL
,	NULL
INSERM	NULL
U.91	NULL
,	NULL
Hopital	NULL
Henri	NULL
Mondor	NULL
,	NULL
51	NULL
avenue	NULL
du	NULL
Maréchal	NULL
de	NULL
Lattre	NULL
de	NULL
Tas-signy	NULL
,	NULL
94010	NULL
Créteil	NULL
,	NULL
France	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/94/84	NULL
1	NULL
1-0006	NULL
$	NULL
3.00/0	NULL
3819	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3820	NULL
no	NULL
regulatory	NULL
sequences	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
this	NULL
transcriptionally	NULL
complex	NULL
locus	NULL
.	NULL

In	NULL
a	NULL
first	NULL
attempt	NULL
to	NULL
define	NULL
the	NULL
regulatory	NULL
elements	NULL
that	NULL
control	NULL
tal-1	NULL
expression	NULL
,	NULL
we	NULL
investigated	NULL
tal-1	NULL
chromatin	NULL
structure	NULL
(	NULL
as	NULL
probed	NULL
by	NULL
its	NULL
methylation	NULL
status	NULL
and	NULL
hypersensitivity	NULL
to	NULL
DNase-I	NULL
)	NULL
in	NULL
erythroid/megakaryocytic	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
in	NULL
different	NULL
T-cell	NULL
lines	NULL
expressing	NULL
tal-1	NULL
gene	NULL
with	NULL
or	NULL
without	NULL
any	NULL
reported	NULL
structural	NULL
alteration	NULL
of	NULL
the	NULL
locus	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
tal-1	NULL
transcription	NULL
is	NULL
monoallelic	NULL
in	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
,	NULL
that	NULL
tal-1	NULL
5°	NULL
GC	NULL
rich	NULL
region	NULL
behaves	NULL
like	NULL
a	NULL
CpG	NULL
island	NULL
,	NULL
and	NULL
that	NULL
the	NULL
preferential	NULL
use	NULL
of	NULL
the	NULL
different	NULL
tal-1	NULL
promoters	NULL
,	NULL
ie	NULL
,	NULL
promoters	NULL
la	NULL
and	NULL
1b	NULL
in	NULL
erythroid/megakaryocytic	NULL
cell	NULL
lines	NULL
,	NULL
promoter	NULL
1b	NULL
in	NULL
Jurkat	NULL
,	NULL
and	NULL
promoter	NULL
exon	NULL
4	NULL
in	NULL
DU5S28	NULL
,	NULL
is	NULL
associated	NULL
with	NULL
specific	NULL
DNase-I	NULL
hypersensitive	NULL
sites	NULL
(	NULL
HS	NULL
)	NULL
located	NULL
in	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
tal-1	NULL
locus	NULL
.	NULL

MATERIAL	NULL
AND	NULL
METHODS	NULL
Tissues	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

Human	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
Dul-becco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
HELA	NULL
)	NULL
or	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
HEL	NULL
,	NULL
K562	NULL
,	NULL
JURKAT	NULL
,	NULL
PEER	NULL
,	NULL
HUT78	NULL
)	NULL
or	NULL
20	NULL
%	NULL
(	NULL
DUS28	NULL
)	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
1-glutamine	NULL
,	NULL
penicillin	NULL
,	NULL
and	NULL
streptomycin	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Normal	NULL
human	NULL
dermic	NULL
fibroblasts	NULL
were	NULL
a	NULL
gift	NULL
of	NULL
Latifa	NULL
Hilal	NULL
(	NULL
INSERM	NULL
U	NULL
91	NULL
,	NULL
Créteil	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Monocytes	NULL
cells	NULL
were	NULL
a	NULL
gift	NULL
of	NULL
S.	NULL
Lachance	NULL
(	NULL
INSERM	NULL
U	NULL
91	NULL
,	NULL
Créteil	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
by	NULL
Ficoll-Paque	NULL
density	NULL
centrifugation	NULL
.	NULL

Polymerase	NULL
chain	NULL
reaction	NULL
amplification	NULL
,	NULL
cDNA	NULL
synthesis	NULL
,	NULL
and	NULL
sequence	NULL
analysis	NULL
.	NULL

-	NULL
Primers	NULL
specific	NULL
for	NULL
the	NULL
5	NULL
'	NULL
part	NULL
of	NULL
tal-1	NULL
exon	NULL
6	NULL
(	NULL
5	NULL
``	NULL
GGCGTATCTTCACCAACAGC	NULL
3	NULL
'	NULL
and	NULL
5°	NULL
ATTCTCACCCCA-CCTGCCCT	NULL
3	NULL
'	NULL
)	NULL
correspond	NULL
to	NULL
sequences	NULL
located	NULL
between	NULL
nucleo-tides	NULL
779	NULL
to	NULL
798	NULL
and	NULL
1275	NULL
to	NULL
1294	NULL
(	NULL
according	NULL
to	NULL
Bernard	NULL
et	NULL
al	NULL
``	NULL
)	NULL
and	NULL
specifically	NULL
amplify	NULL
a	NULL
514-bp	NULL
fragment	NULL
.	NULL

Reactions	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
instructions	NULL
(	NULL
Perkin	NULL
Elmer	NULL
,	NULL
Roche	NULL
Molecular	NULL
Systems	NULL
,	NULL
Branchburg	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
was	NULL
performed	NULL
directly	NULL
on	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
products	NULL
or	NULL
PCR	NULL
fragments	NULL
cloned	NULL
into	NULL
T-vectors	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
using	NULL
a	NULL
Taq	NULL
DyeDeoxy	NULL
Terminator	NULL
Cycle	NULL
Sequencing	NULL
Kit	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
an	NULL
automatic	NULL
sequencer	NULL
(	NULL
373A	NULL
apparatus	NULL
;	NULL
Applied	NULL
Biosystems	NULL
)	NULL
.	NULL

PolyA+	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
the	NULL
JURKAT	NULL
cell	NULL
line	NULL
using	NULL
a	NULL
QuickPrep	NULL
micromRNA	NULL
Purification	NULL
Kit	NULL
(	NULL
Pharmacia	NULL
,	NULL
Milwaukee	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

First-strand	NULL
cDNA	NULL
was	NULL
synthesized	NULL
in	NULL
a	NULL
50-uL	NULL
reaction	NULL
containing	NULL
1	NULL
ug	NULL
polyA+	NULL
RNA	NULL
,	NULL
20	NULL
U	NULL
human	NULL
placenta	NULL
RNAse	NULL
inhibitor	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
,	NULL
100	NULL
mmol/L	NULL
Tris	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
140	NULL
mmol/L	NULL
KCI	NULL
,	NULL
10	NULL
mmol/	NULL
L	NULL
MgC	NULL
)	NULL
,	NULL
28	NULL
mmol/L	NULL
3-mercaptoethanol	NULL
,	NULL
1	NULL
mmol/L	NULL
of	NULL
each	NULL
dNTP	NULL
,	NULL
12	NULL
U	NULL
of	NULL
AMV	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
and	NULL
80	NULL
mmol/L	NULL
hexanucleotides	NULL
.	NULL

The	NULL
reaction	NULL
mix	NULL
was	NULL
incubated	NULL
for	NULL
40	NULL
minutes	NULL
at	NULL
42°C	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
.	NULL

Amplification	NULL
was	NULL
performed	NULL
by	NULL
diluting	NULL
1	NULL
4L	NULL
of	NULL
first-strand	NULL
cDNA	NULL
into	NULL
a	NULL
50-4uL	NULL
PCR	NULL
reaction	NULL
.	NULL

Nuclei	NULL
preparation	NULL
and	NULL
DNase-I	NULL
treatment	NULL
.	NULL

-	NULL
Approximately	NULL
1	NULL
%	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
resuspended	NULL
in	NULL
20	NULL
mL	NULL
homogeneization	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
15	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
60	NULL
mmol/L	NULL
KCI	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.1	NULL
mmol/	NULL
L	NULL
EGTA	NULL
,	NULL
0.15	NULL
mmol/L	NULL
spermine	NULL
,	NULL
0.5	NULL
mmol/L	NULL
spermidine	NULL
,	NULL
5	NULL
%	NULL
su-crose	NULL
)	NULL
containing	NULL
0.05	NULL
%	NULL
(	NULL
T-cell	NULL
lines	NULL
)	NULL
,	NULL
0.2	NULL
%	NULL
(	NULL
erythroid/megakaryo-cytic	NULL
cell	NULL
lines	NULL
)	NULL
,	NULL
or	NULL
0.6	NULL
%	NULL
(	NULL
HELA	NULL
)	NULL
NP4O0	NULL
,	NULL
and	NULL
broken	NULL
by	NULL
five	NULL
strokes	NULL
of	NULL
Dounce	NULL
homogenizer	NULL
with	NULL
B	NULL
pestle	NULL
(	NULL
Kontes	NULL
Glass	NULL
Co	NULL
,	NULL
Vineland	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Nuclei	NULL
were	NULL
purified	NULL
by	NULL
centrifugation	NULL
over	NULL
a	NULL
sucrose	NULL
gradient	NULL
(	NULL
10	NULL
%	NULL
sucrose	NULL
in	NULL
homogeneization	NULL
buffer	NULL
)	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
wash	NULL
buffer	NULL
(	NULL
15	NULL
mmol/L	NULL
Tris	NULL
pH	NULL
,	NULL
7.4	NULL
,	NULL
15	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
60	NULL
mmol/L	NULL
KCI	NULL
,	NULL
0.15	NULL
mmol/L	NULL
Spermine	NULL
,	NULL
0.5	NULL
mmol/L	NULL
spermidine	NULL
,	NULL
10	NULL
%	NULL
sucrose	NULL
)	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
increasing	NULL
concentrations	NULL
of	NULL
DNase-I	NULL
(	NULL
0.1	NULL
ug/mL	NULL
to	NULL
15	NULL
LEROY-VIARD	NULL
ET	NULL
AL	NULL
a	NULL
)	NULL
*	NULL
CCC	NULL
-	NULL
AAG	NULL
CAC	NULL
ACG	NULL
GCC	NULL
C	NULL
@	NULL
c	NULL
acc	NULL
CTC	NULL
A	NULL
b	NULL
)	NULL
*	NULL
CCC	NULL
AAG	NULL
CAC	NULL
ACG	NULL
GCC	NULL
CGC	NULL
AGC	NULL
CTC	NULL
CCC	NULL
AAG	NULL
CAC	NULL
ACG	NULL
ACC	NULL
Cac	NULL
AGC	NULL
CTC	NULL
c	NULL
)	NULL
*	NULL
CCC	NULL
AAG	NULL
CAC	NULL
ACG	NULL
GCC	NULL
CGC	NULL
AGC	NULL
CTC	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
Sequence	NULL
analysis	NULL
around	NULL
nt	NULL
1156	NULL
{	NULL
codon	NULL
314	NULL
)	NULL
of	NULL
tal-1	NULL
genomic	NULL
DNA	NULL
and	NULL
cDNA	NULL
.	NULL

*DNA	NULL
polymorphism	NULL
observed	NULL
at	NULL
nucleotide	NULL
1156	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Direct	NULL
sequencing	NULL
of	NULL
amplified	NULL
genomic	NULL
JURKAT	NULL
DNA	NULL
;	NULL
(	NULL
b	NULL
)	NULL
sequences	NULL
of	NULL
two	NULL
subclones	NULL
obtained	NULL
after	NULL
cloning	NULL
the	NULL
514-bp	NULL
amplified	NULL
product	NULL
;	NULL
(	NULL
c	NULL
)	NULL
direct	NULL
sequencing	NULL
of	NULL
Jurkat	NULL
cDNA	NULL
.	NULL

ug/mL	NULL
;	NULL
Worthington	NULL
,	NULL
Freehold	NULL
,	NULL
NJ	NULL
)	NULL
in	NULL
wash	NULL
buffer	NULL
plus	NULL
1	NULL
mmol/L	NULL
MgC1	NULL
,	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
37°C	NULL
.	NULL

Reaction	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
proteinase	NULL
K	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
0.1	NULL
mg/ml	NULL
)	NULL
,	NULL
sodium	NULL
dodecyl	NULL
!	NULL

sulfate	NULL
(	NULL
SDS	NULL
;	NULL
final	NULL
concentration	NULL
,	NULL
1	NULL
%	NULL
)	NULL
,	NULL
and	NULL
EDTA	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
10	NULL
mmol/L	NULL
)	NULL
.	NULL

DNA	NULL
extraction	NULL
and	NULL
Southern	NULL
hybridization	NULL
.	NULL

-	NULL
DNA	NULL
was	NULL
extracted	NULL
by	NULL
proteinase	NULL
K	NULL
digestion	NULL
(	NULL
0.1	NULL
or	NULL
0.2	NULL
mg/mL	NULL
)	NULL
at	NULL
56°C	NULL
overnight	NULL
.	NULL

phenol	NULL
chloroform	NULL
extraction	NULL
,	NULL
and	NULL
ethanol	NULL
precipitation	NULL
.	NULL

DNA	NULL
,	NULL
10	NULL
ug	NULL
,	NULL
was	NULL
digested	NULL
to	NULL
completion	NULL
with	NULL
the	NULL
indicated	NULL
restriction	NULL
en-zymes	NULL
,	NULL
electrophoresed	NULL
on	NULL
0.8	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
(	NULL
Hybond	NULL
C	NULL
Extra	NULL
;	NULL
Amersham	NULL
,	NULL
Les	NULL
Ulis	NULL
,	NULL
France	NULL
)	NULL
by	NULL
Southern	NULL
blotting	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
with	NULL
random	NULL
primed	NULL
P-labeled	NULL
probes	NULL
at	NULL
65°C	NULL
in	NULL
5	NULL
%	NULL
SSC	NULL
(	NULL
0.6	NULL
mol/L	NULL
NaCl	NULL
,	NULL
0.06	NULL
mol/L	NULL
Na	NULL
citrate	NULL
,	NULL
pH	NULL
7	NULL
)	NULL
,	NULL
1	NULL
%	NULL
Denhardt	NULL
's	NULL
mix	NULL
,	NULL
20	NULL
mmol/L	NULL
NaPO	NULL
,	NULL
,	NULL
pH	NULL
6.7	NULL
,	NULL
and	NULL
10	NULL
%	NULL
dextran	NULL
sulfate	NULL
.	NULL

Highest-stringency	NULL
washes	NULL
consisted	NULL
of	NULL
0.1	NULL
%	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
65°C	NULL
.	NULL

The	NULL
genomic	NULL
probes	NULL
used	NULL
are	NULL
probe	NULL
1	NULL
(	NULL
a	NULL
1.5-kb	NULL
Mbol-Xhol	NULL
fragment	NULL
)	NULL
,	NULL
probe	NULL
2	NULL
(	NULL
a	NULL
2.2-kb	NULL
Xhol	NULL
fragment	NULL
)	NULL
,	NULL
and	NULL
probe	NULL
3	NULL
(	NULL
a	NULL
1.4-kb	NULL
BamHI-Kprni	NULL
fragment	NULL
)	NULL
for	NULL
the	NULL
methylation	NULL
studies	NULL
;	NULL
and	NULL
probe	NULL
HX	NULL
(	NULL
a	NULL
0.5-kb	NULL
Xbal-HindIH	NULL
fragment	NULL
)	NULL
and	NULL
probe	NULL
Bg-B	NULL
(	NULL
a	NULL
1-kb	NULL
Bglll-BamHI	NULL
fragment	NULL
)	NULL
for	NULL
the	NULL
DNase-I	NULL
studies	NULL
.	NULL

The	NULL
location	NULL
of	NULL
these	NULL
probes	NULL
within	NULL
tal-1	NULL
locus	NULL
is	NULL
indicated	NULL
in	NULL
the	NULL
figures	NULL
.	NULL

RESULTS	NULL
Expression	NULL
of	NULL
the	NULL
tal-1	NULL
gene	NULL
is	NULL
monoallelic	NULL
in	NULL
the	NULL
JURKAT	NULL
T-cell	NULL
line	NULL
.	NULL

The	NULL
JURKAT	NULL
T-cell	NULL
line	NULL
,	NULL
established	NULL
from	NULL
a	NULL
T-ALL	NULL
,	NULL
transcribes	NULL
tal-1	NULL
at	NULL
high	NULL
levels	NULL
,	NULL
although	NULL
it	NULL
is	NULL
not	NULL
associated	NULL
with	NULL
1p32	NULL
chromosomal	NULL
alteration	NULL
.	NULL

By	NULL
Southern	NULL
blot	NULL
analysis	NULL
using	NULL
probes	NULL
encompassing	NULL
50	NULL
kb	NULL
of	NULL
the	NULL
tal-	NULL
I	NULL
locus	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
genomic	NULL
rearrangement	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
result	NULL
,	NULL
together	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
JURKAT	NULL
transcription	NULL
of	NULL
tal-1	NULL
was	NULL
mainly	NULL
initiated	NULL
from	NULL
the	NULL
promoter	NULL
1b	NULL
,	NULL
and	NULL
to	NULL
a	NULL
much	NULL
lesser	NULL
extent	NULL
from	NULL
the	NULL
promoter	NULL
located	NULL
in	NULL
exon	NULL
4	NULL
,	NULL
``	NULL
prompted	NULL
us	NULL
to	NULL
determine	NULL
whether	NULL
one	NULL
or	NULL
both	NULL
alleles	NULL
were	NULL
transcriptionally	NULL
active	NULL
.	NULL

Direct	NULL
sequencing	NULL
of	NULL
tal-1	NULL
exon	NULL
6	NULL
showed	NULL
a	NULL
DNA	NULL
polymorphism	NULL
at	NULL
the	NULL
nucleotide	NULL
(	NULL
nt	NULL
)	NULL
1156	NULL
(	NULL
A	NULL
or	NULL
G	NULL
)	NULL
(	NULL
according	NULL
to	NULL
the	NULL
numbering	NULL
used	NULL
by	NULL
Bernard	NULL
et	NULL
al	NULL
``	NULL
)	NULL
in	NULL
Jurkat	NULL
genomic	NULL
DNA	NULL
(	NULL
Fig	NULL
1a	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
polymorphism	NULL
,	NULL
we	NULL
cloned	NULL
PCR	NULL
products	NULL
encompassing	NULL
the	NULL
beginning	NULL
of	NULL
exon	NULL
6	NULL
and	NULL
sequenced	NULL
several	NULL
clones	NULL
.	NULL

Two	NULL
types	NULL
of	NULL
subclones	NULL
were	NULL
obtained	NULL
:	NULL
one	NULL
with	NULL
nt	NULL
1156	NULL
=	NULL
G	NULL
,	NULL
as	NULL
expected	NULL
from	NULL
published	NULL
sequences	NULL
,	NULL
and	NULL
the	NULL
other	NULL
with	NULL
nt	NULL
1156	NULL
=	NULL
A	NULL
(	NULL
Fig	NULL
1b	NULL
)	NULL
.	NULL

PolyA+	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
Jurkat	NULL
cells	NULL
,	NULL
reverse-transcribed	NULL
,	NULL
and	NULL
the	NULL
cDNA	NULL
produced	NULL
directly	NULL
sequenced	NULL
after	NULL
PCR	NULL
amplification	NULL
.	NULL

Sequences	NULL
of	NULL
cDNAs	NULL
from	NULL
Jurkat	NULL
cell	NULL
line	NULL
or	NULL
from	NULL
a	NULL
clonal	NULL
cell	NULL
population	NULL
derived	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CHROMATIN	NULL
STRUCTURE	NULL
OF	NULL
TAL1	NULL
GENE	NULL
from	NULL
this	NULL
line	NULL
displayed	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
incorporation	NULL
of	NULL
dideoxynucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
normal	NULL
nt	NULL
1156	NULL
G	NULL
on	NULL
either	NULL
strands	NULL
(	NULL
Fig	NULL
1c	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
data	NULL
can	NULL
not	NULL
formally	NULL
rule	NULL
out	NULL
a	NULL
weak	NULL
transcription	NULL
of	NULL
the	NULL
allele	NULL
bearing	NULL
the	NULL
polymorphic	NULL
nt	NULL
1156	NULL
A	NULL
,	NULL
they	NULL
strongly	NULL
suggest	NULL
that	NULL
tal-1	NULL
transcription	NULL
is	NULL
consecutive	NULL
to	NULL
a	NULL
cis-activating	NULL
mechanism	NULL
and	NULL
most	NULL
probably	NULL
monoallelic	NULL
in	NULL
the	NULL
Jurkat	NULL
cell	NULL
line	NULL
.	NULL

Methylation	NULL
status	NULL
of	NULL
the	NULL
tal-1	NULL
locus	NULL
in	NULL
established	NULL
cell	NULL
lines	NULL
and	NULL
in	NULL
normal	NULL
cells	NULL
.	NULL

DNA	NULL
methylation	NULL
on	NULL
CpG	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Since	NULL
the	NULL
5	NULL
'	NULL
noncoding	NULL
part	NULL
of	NULL
tal-1	NULL
transcription	NULL
unit	NULL
lies	NULL
in	NULL
a	NULL
highly	NULL
G	NULL
+	NULL
C-rich	NULL
region	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
methylation	NULL
status	NULL
of	NULL
the	NULL
actively	NULL
transcribed	NULL
tal-1	NULL
gene	NULL
in	NULL
the	NULL
erythroid/megakaryocytic	NULL
cell	NULL
lines	NULL
HEL	NULL
and	NULL
K562	NULL
,	NULL
and	NULL
in	NULL
T-cell	NULL
lines	NULL
with	NULL
or	NULL
without	NULL
any	NULL
reported	NULL
genomic	NULL
alteration	NULL
of	NULL
the	NULL
locus	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
T-cell	NULL
lines	NULL
in	NULL
which	NULL
the	NULL
locus	NULL
is	NULL
silent	NULL
.	NULL

Genomic	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
Hpall	NULL
or	NULL
MspI	NULL
and	NULL
analyzed	NULL
by	NULL
Southern	NULL
blotting	NULL
for	NULL
methylation	NULL
of	NULL
the	NULL
tal-1	NULL
gene	NULL
using	NULL
probes	NULL
located	NULL
either	NULL
in	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
transcription	NULL
unit	NULL
,	NULL
or	NULL
in	NULL
the	NULL
exon	NULL
4	NULL
region	NULL
,	NULL
which	NULL
is	NULL
also	NULL
characterized	NULL
by	NULL
a	NULL
high	NULL
GC	NULL
content	NULL
.	NULL

Complete	NULL
digestion	NULL
by	NULL
Hpall	NULL
was	NULL
attested	NULL
by	NULL
hybridizing	NULL
the	NULL
same	NULL
blots	NULL
with	NULL
a	NULL
probe	NULL
located	NULL
in	NULL
the	NULL
CpG	NULL
island	NULL
of	NULL
the	NULL
housekeeping	NULL
gene	NULL
,	NULL
uroporphyrinogen	NULL
decarboxylase	NULL
(	NULL
Uro-D	NULL
)	NULL
.	NULL

A	NULL
detailed	NULL
map	NULL
of	NULL
the	NULL
tal-1	NULL
genomic	NULL
region	NULL
,	NULL
MspI	NULL
sites	NULL
,	NULL
and	NULL
probes	NULL
used	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
2A	NULL
,	NULL
and	NULL
representative	NULL
autoradiographs	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
2B	NULL
and	NULL
C.	NULL
The	NULL
5	NULL
'	NULL
part	NULL
of	NULL
tal-	NULL
1	NULL
locus	NULL
is	NULL
unmethylated	NULL
in	NULL
cell	NULL
lines	NULL
that	NULL
express	NULL
tal-1	NULL
from	NULL
the	NULL
promoters	NULL
la	NULL
and	NULL
1b	NULL
such	NULL
as	NULL
HEL	NULL
or	NULL
K562	NULL
,	NULL
since	NULL
hybridization	NULL
with	NULL
probe	NULL
1	NULL
identified	NULL
one	NULL
major	NULL
band	NULL
of	NULL
0.8	NULL
kb	NULL
and	NULL
probe	NULL
2	NULL
three	NULL
bands	NULL
of	NULL
0.74	NULL
kb	NULL
,	NULL
0.45	NULL
kb	NULL
,	NULL
and	NULL
0.3	NULL
kb	NULL
in	NULL
both	NULL
MspI	NULL
and	NULL
Hpall	NULL
digests	NULL
.	NULL

In	NULL
T-cell	NULL
lines	NULL
that	NULL
do	NULL
not	NULL
express	NULL
tal-1	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
these	NULL
Mspl-like	NULL
Hpall	NULL
fragments	NULL
,	NULL
but	NULL
higher	NULL
molecular	NULL
weight	NULL
bands	NULL
(	NULL
0.96	NULL
kb	NULL
with	NULL
probe	NULL
1	NULL
,	NULL
1.6	NULL
kb	NULL
with	NULL
probe	NULL
2	NULL
in	NULL
HUT78	NULL
,	NULL
3	NULL
kb	NULL
and	NULL
6	NULL
kb	NULL
fragments	NULL
with	NULL
either	NULL
probes	NULL
in	NULL
Peer	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
this	NULL
part	NULL
of	NULL
the	NULL
locus	NULL
was	NULL
mildly	NULL
methylated	NULL
in	NULL
HUT78	NULL
cells	NULL
,	NULL
and	NULL
highly	NULL
methylated	NULL
in	NULL
PEER	NULL
cells	NULL
.	NULL

In	NULL
JURKAT	NULL
cells	NULL
,	NULL
the	NULL
probe	NULL
1	NULL
hybridized	NULL
simultaneously	NULL
to	NULL
a	NULL
Mspl-like	NULL
Hpall	NULL
fragment	NULL
of	NULL
0.8	NULL
kb	NULL
and	NULL
to	NULL
higher	NULL
molecular	NULL
weight	NULL
Hpall	NULL
fragments	NULL
of	NULL
1.2	NULL
kb	NULL
and	NULL
3	NULL
kb	NULL
.	NULL

The	NULL
probe	NULL
2	NULL
identified	NULL
three	NULL
Mspl-like	NULL
Hpall	NULL
fragments	NULL
of	NULL
0.74	NULL
kb	NULL
,	NULL
0.45	NULL
kb	NULL
,	NULL
and	NULL
0.3	NULL
kb	NULL
,	NULL
but	NULL
also	NULL
larger	NULL
Hpall	NULL
fragments	NULL
of	NULL
1.6	NULL
kb	NULL
and	NULL
3	NULL
kb	NULL
.	NULL

Since	NULL
we	NULL
showed	NULL
that	NULL
tal-1	NULL
transcription	NULL
is	NULL
most	NULL
probably	NULL
monoallelic	NULL
in	NULL
JURKAT	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
transcriptionally	NULL
active	NULL
allele	NULL
is	NULL
methylation-free	NULL
,	NULL
whereas	NULL
the	NULL
inactive	NULL
allele	NULL
is	NULL
not	NULL
.	NULL

A	NULL
similar	NULL
pattern	NULL
of	NULL
Hpall	NULL
digestion	NULL
,	NULL
characterized	NULL
by	NULL
the	NULL
simultaneous	NULL
presence	NULL
of	NULL
Mspl-like	NULL
and	NULL
larger	NULL
Hpall	NULL
fragments	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
SKW3	NULL
and	NULL
Molt4	NULL
,	NULL
two	NULL
T-cell	NULL
lines	NULL
reported	NULL
to	NULL
express	NULL
tal1	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
local	NULL
genomic	NULL
alteration	NULL
``	NULL
(	NULL
and	NULL
our	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
CEM	NULL
T-cell	NULL
line	NULL
,	NULL
which	NULL
bears	NULL
the	NULL
SIL-tal	NULL
d1	NULL
type	NULL
of	NULL
deletion	NULL
(	NULL
with	NULL
a	NULL
tal-1	NULL
breakpoint	NULL
located	NULL
between	NULL
exons	NULL
1a	NULL
and	NULL
1b	NULL
)	NULL
,	NULL
exhibited	NULL
hypomethylation	NULL
of	NULL
the	NULL
rearranged	NULL
allele	NULL
in	NULL
its	NULL
5	NULL
``	NULL
part	NULL
(	NULL
the	NULL
probe	NULL
1	NULL
hybridized	NULL
to	NULL
a	NULL
rearranged	NULL
Mspl-like	NULL
1.1-kb	NULL
Hpall	NULL
fragment	NULL
and	NULL
to	NULL
Hpall	NULL
fragments	NULL
of	NULL
1.2	NULL
kb	NULL
,	NULL
2.4	NULL
kb	NULL
,	NULL
and	NULL
3	NULL
kb	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
downstream	NULL
region	NULL
appeared	NULL
highly	NULL
methylated	NULL
(	NULL
the	NULL
probe	NULL
2	NULL
hybridized	NULL
to	NULL
1.6-kb	NULL
,	NULL
3-kb	NULL
,	NULL
and	NULL
6-kb	NULL
Hpall	NULL
fragments	NULL
)	NULL
.	NULL

The	NULL
DUS28	NULL
cell	NULL
line	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
affecting	NULL
3821	NULL
the	NULL
3	NULL
'	NULL
noncoding	NULL
part	NULL
of	NULL
the	NULL
sixth	NULL
exon	NULL
and	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
initiate	NULL
tal-1	NULL
transcription	NULL
exclusively	NULL
within	NULL
the	NULL
tal-1	NULL
fourth	NULL
exon	NULL
.	NULL
``	NULL

Analysis	NULL
of	NULL
tal-1	NULL
methylation	NULL
status	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
showed	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
methylation	NULL
in	NULL
the	NULL
5	NULL
'	NULL
part	NULL
of	NULL
the	NULL
locus	NULL
,	NULL
whereas	NULL
the	NULL
fourth	NULL
exon	NULL
initiation	NULL
region	NULL
is	NULL
unmethylated	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
exon	NULL
4	NULL
flanking	NULL
region	NULL
was	NULL
hypomethylated	NULL
in	NULL
all	NULL
the	NULL
cell	NULL
lines	NULL
we	NULL
tested	NULL
regardless	NULL
of	NULL
tal-	NULL
1	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
methylation	NULL
patterns	NULL
observed	NULL
in	NULL
most	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
studied	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

Because	NULL
transcription	NULL
and	NULL
absence	NULL
of	NULL
methylation	NULL
seemed	NULL
to	NULL
be	NULL
correlated	NULL
,	NULL
we	NULL
assessed	NULL
whether	NULL
methylation	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
repression	NULL
of	NULL
tal-1	NULL
expression	NULL
in	NULL
normal	NULL
tissues	NULL
.	NULL

We	NULL
therefore	NULL
explored	NULL
the	NULL
methylation	NULL
status	NULL
of	NULL
the	NULL
5°	NULL
GC-rich	NULL
region	NULL
in	NULL
normal	NULL
cells	NULL
that	NULL
do	NULL
not	NULL
express	NULL
tal-1	NULL
,	NULL
ie	NULL
,	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
,	NULL
leukocytes	NULL
,	NULL
and	NULL
fibroblasts	NULL
.	NULL

Figure	NULL
2C	NULL
clearly	NULL
shows	NULL
that	NULL
the	NULL
tal-1	NULL
5	NULL
'	NULL
region	NULL
is	NULL
methylation-free	NULL
in	NULL
these	NULL
three	NULL
tissues	NULL
.	NULL

Together	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
tal-1	NULL
5°	NULL
GC-rich	NULL
region	NULL
behaves	NULL
like	NULL
a	NULL
CpG	NULL
island	NULL
:	NULL
it	NULL
is	NULL
methylation-free	NULL
in	NULL
vivo	NULL
,	NULL
whether	NULL
transcribed	NULL
or	NULL
not	NULL
,	NULL
and	NULL
becomes	NULL
methylated	NULL
on	NULL
transcriptionally	NULL
inactive	NULL
alleles	NULL
in	NULL
established	NULL
cell	NULL
lines	NULL
.	NULL

Specific	NULL
DNase-I	NULL
HS	NULL
are	NULL
associated	NULL
with	NULL
the	NULL
preferential	NULL
use	NULL
of	NULL
the	NULL
different	NULL
tal-1	NULL
promoters	NULL
.	NULL

-	NULL
Hypersensitivity	NULL
of	NULL
chromatin	NULL
to	NULL
DNase-I	NULL
digestion	NULL
has	NULL
been	NULL
used	NULL
to	NULL
identify	NULL
regulatory	NULL
elements	NULL
of	NULL
several	NULL
genes	NULL
.	NULL

``	NULL
``	NULL
*	NULL
``	NULL
To	NULL
determine	NULL
which	NULL
regions	NULL
of	NULL
the	NULL
tal-1	NULL
locus	NULL
might	NULL
be	NULL
implicated	NULL
in	NULL
the	NULL
control	NULL
of	NULL
its	NULL
expression	NULL
,	NULL
either	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
erythroid/	NULL
megakaryocytic	NULL
lineage	NULL
or	NULL
in	NULL
leukemic	NULL
T-cell	NULL
lines	NULL
,	NULL
we	NULL
mapped	NULL
DNase-I	NULL
HS	NULL
in	NULL
45	NULL
kb	NULL
of	NULL
genomic	NULL
DNA	NULL
encompassing	NULL
the	NULL
tal-1	NULL
transcription	NULL
unit	NULL
.	NULL

Figure	NULL
3	NULL
shows	NULL
the	NULL
mapping	NULL
of	NULL
DNase	NULL
HS	NULL
after	NULL
HindIII	NULL
digestion	NULL
and	NULL
hybridization	NULL
with	NULL
a	NULL
3	NULL
'	NULL
HindlII-Xbal	NULL
probe	NULL
in	NULL
HEL	NULL
,	NULL
K562	NULL
,	NULL
JURKAT	NULL
,	NULL
PEER	NULL
,	NULL
HUT78	NULL
,	NULL
and	NULL
DUS28	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
germline	NULL
20-kb	NULL
fragment	NULL
,	NULL
several	NULL
additional	NULL
fragments	NULL
were	NULL
detected	NULL
.	NULL

Two	NULL
fragments	NULL
of	NULL
1.7	NULL
and	NULL
1.9	NULL
kb	NULL
(	NULL
HS	NULL
Va	NULL
and	NULL
b	NULL
)	NULL
and	NULL
a	NULL
fragment	NULL
of	NULL
4.8	NULL
kb	NULL
(	NULL
HS	NULL
IV	NULL
)	NULL
were	NULL
exclusively	NULL
observed	NULL
in	NULL
HEL	NULL
and	NULL
K562	NULL
.	NULL

HS	NULL
Va	NULL
and	NULL
Vb	NULL
were	NULL
more	NULL
intense	NULL
in	NULL
K562	NULL
,	NULL
whereas	NULL
HS	NULL
IV	NULL
was	NULL
more	NULL
intense	NULL
in	NULL
HEL	NULL
.	NULL

The	NULL
probe	NULL
hybridized	NULL
strongly	NULL
to	NULL
a	NULL
11.6-kb	NULL
fragment	NULL
in	NULL
Jurkat	NULL
(	NULL
HS	NULL
ID	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
already	NULL
present	NULL
,	NULL
albeit	NULL
more	NULL
faintly	NULL
,	NULL
in	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
not	NULL
been	NULL
treated	NULL
with	NULL
DNase-I	NULL
(	NULL
lane	NULL
0	NULL
)	NULL
,	NULL
probably	NULL
because	NULL
of	NULL
endogenous	NULL
DNases	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
this	NULL
fragment	NULL
augmented	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
DNase-I	NULL
,	NULL
whereas	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
germline	NULL
fragment	NULL
decreased	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
region	NULL
is	NULL
highly	NULL
sensitive	NULL
to	NULL
DNase-I	NULL
in	NULL
Jurkat	NULL
.	NULL

A	NULL
very	NULL
faint	NULL
band	NULL
of	NULL
the	NULL
same	NULL
size	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
HEL	NULL
,	NULL
K562	NULL
,	NULL
DUS28	NULL
,	NULL
HUT78	NULL
,	NULL
and	NULL
Peer	NULL
.	NULL

An	NULL
intense	NULL
band	NULL
of	NULL
7.8	NULL
kb	NULL
(	NULL
HS	NULL
III	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
DU528	NULL
.	NULL

A	NULL
fragment	NULL
of	NULL
a	NULL
similar	NULL
size	NULL
,	NULL
but	NULL
much	NULL
weaker	NULL
in	NULL
intensity	NULL
,	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
HEL	NULL
,	NULL
together	NULL
with	NULL
a	NULL
weak	NULL
6-kb	NULL
fragment	NULL
.	NULL

Rehybridization	NULL
of	NULL
the	NULL
blot	NULL
with	NULL
a	NULL
probe	NULL
located	NULL
in	NULL
the	NULL
sixth	NULL
exon	NULL
did	NULL
not	NULL
show	NULL
any	NULL
HS	NULL
in	NULL
the	NULL
3	NULL
'	NULL
part	NULL
of	NULL
the	NULL
locus	NULL
in	NULL
HEL	NULL
,	NULL
K562	NULL
,	NULL
and	NULL
Jurkat	NULL
cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
map	NULL
these	NULL
DNase-I	NULL
HS	NULL
more	NULL
precisely	NULL
,	NULL
we	NULL
used	NULL
the	NULL
3	NULL
``	NULL
BamHI-BgIll	NULL
probe	NULL
on	NULL
BamHI-digested	NULL
DNAs	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
16.5-kb	NULL
germline	NULL
fragment	NULL
,	NULL
we	NULL
observed	NULL
an	NULL
intense	NULL
2.3	NULL
kb	NULL
(	NULL
HS	NULL
III	NULL
)	NULL
fragment	NULL
in	NULL
DUS28	NULL
,	NULL
which	NULL
was	NULL
very	NULL
weak	NULL
in	NULL
HEL	NULL
and	NULL
Jurkat	NULL
lines	NULL
;	NULL
an	NULL
intense	NULL
6.1-kb	NULL
(	NULL
HS	NULL
II	NULL
)	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3822	NULL
5	NULL
Mola	NULL
ib	NULL
*	NULL
ib	NULL
tta	NULL
in	NULL
*	NULL
80	NULL
y	NULL
,	NULL
«	NULL
224	NULL
L	NULL
_CL	NULL
0	NULL
©	NULL
|	NULL
r	NULL
|__	NULL
[	NULL
|_|	NULL
3	NULL
``	NULL
-	NULL
|_	NULL
TTT	NULL
MT	NULL
1	NULL
IT	NULL
WTT	NULL
UI	NULL
TTT	NULL
MI	NULL
T1	NULL
I	NULL
sites	NULL
1	NULL
?	NULL

3	NULL
C	NULL
Serac	NULL
its	NULL
&	NULL
o	NULL
F	NULL
~	NULL
<	NULL
\Q	NULL
’	NULL
\~	NULL
'	NULL
<	NULL
\°	NULL
<	NULL
\Q	NULL
‘	NULL
°€o§§	NULL
$	NULL
\io\3°	NULL
$	NULL
@	NULL
$	NULL
¢V~6§99626keﬁéovs°¢	NULL
23.1	NULL
-	NULL
be	NULL
1	NULL
I-	NULL
w	NULL
-	NULL
®	NULL
[	NULL
os	NULL
Kb	NULL
Mbot-Xnoi	NULL
)	NULL
4.4-23.	NULL
he	NULL
%	NULL
2.	NULL
sm	NULL
y	NULL
.	NULL

3	NULL
_	NULL
ye	NULL
®	NULL
13-14-	NULL
we	NULL
..~	NULL
w	NULL
,	NULL
-_	NULL
t-	NULL
1.1	NULL
Kb	NULL
0.9	NULL
-	NULL
ws	NULL
Beo	NULL
@	NULL
euc®	NULL
@	NULL
-	NULL
-	NULL
®	NULL
>	NULL
#	NULL
#	NULL
UD	NULL
we	NULL
«	NULL
a-	NULL
0.8	NULL
Kb	NULL
0.6	NULL
0.3	NULL
#	NULL
-q-	NULL
0.74	NULL
Kb	NULL
e	NULL
-t-	NULL
0.45	NULL
Kb	NULL
os	NULL
.	NULL

-	NULL
dh	NULL
o.	NULL
wt	NULL
=	NULL
as	NULL
<	NULL
-	NULL
0.3	NULL
Kb	NULL
-_.	NULL
civ	NULL
i	NULL
UUP	NULL
was	NULL
<	NULL
-	NULL
0.55	NULL
ko	NULL
#	NULL
4	NULL
``	NULL
``	NULL
C®	NULL
Co	NULL
1	NULL
2	NULL
B	NULL
4	NULL
5	NULL
a	NULL
probe	NULL
2	NULL
(	NULL
2.2	NULL
Kb	NULL
Xhol	NULL
)	NULL
231	NULL
s4	NULL
-	NULL
E	NULL
6.6—w	NULL
‘	NULL
a1	NULL
-	NULL
BE	NULL
``	NULL
(	NULL
te	NULL
23	NULL
-~	NULL
$	NULL
se	NULL
1.35	NULL
-|	NULL
ts	NULL
14—2	NULL
.	NULL

“	NULL
bd	NULL
0.9	NULL
WW	NULL
#	NULL
W	NULL
=	NULL
-a-o74k6	NULL
0.6	NULL
-a-	NULL
0.45	NULL
Kb	NULL
as	NULL
0.3	NULL
-	NULL
ae	NULL
®	NULL
-a-	NULL
0.3	NULL
Kb	NULL
fragment	NULL
in	NULL
Jurkat	NULL
,	NULL
which	NULL
was	NULL
weak	NULL
in	NULL
HEL	NULL
,	NULL
K562	NULL
,	NULL
DU528	NULL
,	NULL
HUT78	NULL
,	NULL
and	NULL
Peer	NULL
lines	NULL
;	NULL
and	NULL
a	NULL
9.4-kb	NULL
(	NULL
HS	NULL
I	NULL
)	NULL
fragment	NULL
in	NULL
the	NULL
erythroid/megakaryocytic	NULL
lines	NULL
.	NULL

No	NULL
DNase-I	NULL
HS	NULL
was	NULL
observed	NULL
in	NULL
Hela	NULL
,	NULL
a	NULL
nonhematopoietic	NULL
cell	NULL
line	NULL
.	NULL

As	NULL
previously	NULL
observed	NULL
in	NULL
HindIII	NULL
digestions	NULL
,	NULL
HS	NULL
II	NULL
was	NULL
already	NULL
present	NULL
LEROY-VIARD	NULL
ET	NULL
AL	NULL
Fig	NULL
2	NULL
.	NULL

Methylation	NULL
analysis	NULL
of	NULL
the	NULL
tal-1	NULL
gene	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Location	NULL
of	NULL
the	NULL
MspI	NULL
sites	NULL
in	NULL
the	NULL
tal-1	NULL
5	NULL
``	NULL
GC	NULL
rich	NULL
region	NULL
and	NULL
exon	NULL
4	NULL
region	NULL
.	NULL

The	NULL
probes	NULL
used	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
)	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

M	NULL
,	NULL
Mbol	NULL
;	NULL
X	NULL
,	NULL
Xhol	NULL
;	NULL
B	NULL
,	NULL
BamHI	NULL
;	NULL
K	NULL
,	NULL
Kpni	NULL
.	NULL

(	NULL
0	NULL
)	NULL
tal-1	NULL
exons	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNAs	NULL
from	NULL
the	NULL
indicated	NULL
cell	NULL
lines	NULL
were	NULL
digested	NULL
with	NULL
Mspl	NULL
or	NULL
Hpall	NULL
,	NULL
electrophoresed	NULL
in	NULL
0.8	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
and	NULL
blotted	NULL
on	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

The	NULL
two	NULL
probes	NULL
used	NULL
are	NULL
indicated	NULL
;	NULL
the	NULL
fragments	NULL
shown	NULL
in	NULL
the	NULL
Mspl	NULL
digests	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

Control	NULL
probe	NULL
is	NULL
a	NULL
1.1-kb	NULL
Hindlll-Ssti	NULL
fragment	NULL
located	NULL
in	NULL
the	NULL
5	NULL
'	NULL
CpG	NULL
island	NULL
of	NULL
the	NULL
human	NULL
Uro-D	NULL
gene	NULL
.	NULL

(	NULL
C	NULL
)	NULL
DNAs	NULL
from	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
monocytes	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
leukocytes	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
fibroblasts	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
were	NULL
digested	NULL
with	NULL
Mspl	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
Hpall	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
5	NULL
)	NULL
,	NULL
electrophoresed	NULL
in	NULL
0.8	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
and	NULL
blotted	NULL
on	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
is	NULL
indicated	NULL
;	NULL
the	NULL
fragments	NULL
shown	NULL
in	NULL
the	NULL
MspI	NULL
digests	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

in	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
not	NULL
been	NULL
treated	NULL
with	NULL
DNase-I	NULL
,	NULL
which	NULL
probably	NULL
reflects	NULL
the	NULL
activity	NULL
of	NULL
endogenous	NULL
DNases	NULL
.	NULL

HS	NULL
I	NULL
was	NULL
not	NULL
previously	NULL
observed	NULL
in	NULL
HEL	NULL
or	NULL
K562	NULL
HindIII-di-gested	NULL
DNAs	NULL
,	NULL
either	NULL
because	NULL
this	NULL
site	NULL
was	NULL
too	NULL
close	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
germline	NULL
fragment	NULL
or	NULL
because	NULL
preferential	NULL
cut	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CHROMATIN	NULL
STRUCTURE	NULL
OF	NULL
TAL1	NULL
GENE	NULL
3823	NULL
Table	NULL
1	NULL
.	NULL

Methylation	NULL
Status	NULL
of	NULL
the	NULL
tal-1	NULL
Gene	NULL
in	NULL
Different	NULL
Established	NULL
Cell	NULL
Lines	NULL
and	NULL
in	NULL
Normal	NULL
Tissues	NULL
Reported	NULL
Methylation	NULL
Methylation	NULL
Methylation	NULL
Alteration	NULL
of	NULL
Expression	NULL
of	NULL
the	NULL
Exons	NULL
of	NULL
the	NULL
Exons	NULL
of	NULL
the	NULL
Exon	NULL
Cell	NULL
Line	NULL
the	NULL
tai-1	NULL
Locus	NULL
of	NULL
tal-1	NULL
1a-1b	NULL
Region	NULL
2b-3	NULL
Region	NULL
4	NULL
Region	NULL
HEL/K562	NULL
No	NULL
Yes/B	NULL
-	NULL
-	NULL
CEM	NULL
Yes	NULL
Yes/M	NULL
-/+	NULL
+	NULL
ND	NULL
DU528	NULL
Yes	NULL
Yes/M	NULL
+	NULL
+	NULL
JURKAT	NULL
No	NULL
Yes/M	NULL
-/+	NULL
-/+	NULL
HUT78	NULL
No	NULL
No	NULL
+	NULL
+	NULL
~	NULL
PEER	NULL
No	NULL
No	NULL
+	NULL
+	NULL
PBL	NULL
No	NULL
No	NULL
-	NULL
-	NULL
Leukocytes	NULL
No	NULL
No	NULL
-	NULL
ND	NULL
Fibroblastes	NULL
No	NULL
No	NULL
-	NULL
-	NULL
NOTE	NULL
.	NULL

Methylation	NULL
was	NULL
assessed	NULL
as	NULL
follows	NULL
:	NULL
-	NULL
,	NULL
similar	NULL
Hpali	NULL
and	NULL
Msp	NULL
!	NULL

digestion	NULL
patterns	NULL
;	NULL
+	NULL
,	NULL
Hpall	NULL
fragments	NULL
larger	NULL
than	NULL
Mspi	NULL
ones	NULL
;	NULL
-/+	NULL
simultaneous	NULL
presence	NULL
of	NULL
Mspl-like	NULL
and	NULL
larger	NULL
Hpall	NULL
fragments	NULL
.	NULL

Abbreviations	NULL
:	NULL
PBL	NULL
,	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
;	NULL
M	NULL
,	NULL
monoallelic	NULL
;	NULL
B	NULL
,	NULL
biallelic	NULL
;	NULL
ND	NULL
,	NULL
not	NULL
done	NULL
.	NULL

ting	NULL
of	NULL
DNase-I	NULL
occurred	NULL
in	NULL
the	NULL
HS	NULL
IV	NULL
and	NULL
V	NULL
regions	NULL
.	NULL

The	NULL
DNase	NULL
sensitivity	NULL
of	NULL
HEL	NULL
chromatin	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
6-kb	NULL
fragment	NULL
in	NULL
HindIII	NULL
digestions	NULL
could	NULL
not	NULL
be	NULL
further	NULL
explored	NULL
with	NULL
the	NULL
BamHI	NULL
digestion	NULL
,	NULL
since	NULL
this	NULL
potential	NULL
DNase-I	NULL
HS	NULL
mapped	NULL
in	NULL
the	NULL
region	NULL
of	NULL
the	NULL
probe	NULL
used	NULL
to	NULL
hybridize	NULL
BamHI	NULL
blots	NULL
.	NULL

DNase-I	NULL
treatment	NULL
followed	NULL
by	NULL
BgIlI	NULL
digestions	NULL
and	NULL
subsequent	NULL
hybridization	NULL
with	NULL
the	NULL
5	NULL
``	NULL
BgIlI-BamHI	NULL
probe	NULL
previously	NULL
used	NULL
in	NULL
the	NULL
BamHI	NULL
studies	NULL
confirmed	NULL
the	NULL
presence	NULL
of	NULL
HS	NULL
IV	NULL
in	NULL
HEL	NULL
and	NULL
indicated	NULL
a	NULL
weak	NULL
DNase-I	NULL
hypersensitivity	NULL
in	NULL
the	NULL
promoter	NULL
1b	NULL
in	NULL
JURKAT	NULL
and	NULL
in	NULL
the	NULL
exon	NULL
4	NULL
promoter	NULL
in	NULL
DU528	NULL
,	NULL
but	NULL
did	NULL
not	NULL
show	NULL
any	NULL
other	NULL
major	NULL
HS	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Figure	NULL
5	NULL
summarizes	NULL
the	NULL
various	NULL
HS	NULL
that	NULL
we	NULL
have	NULL
characterized	NULL
in	NULL
the	NULL
different	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
their	NULL
respective	NULL
location	NULL
within	NULL
the	NULL
tal-1	NULL
locus	NULL
.	NULL

With	NULL
respect	NULL
to	NULL
the	NULL
initiation	NULL
of	NULL
tal-1	NULL
transcription	NULL
in	NULL
the	NULL
exon	NULL
1a	NULL
,	NULL
the	NULL
different	NULL
HS	NULL
identified	NULL
are	NULL
the	NULL
following	NULL
:	NULL
HS	NULL
I	NULL
(	NULL
-10.3	NULL
kb	NULL
)	NULL
,	NULL
HS	NULL
II	NULL
(	NULL
-7	NULL
kb	NULL
)	NULL
,	NULL
HS	NULL
III	NULL
(	NULL
-3.1	NULL
kb	NULL
)	NULL
,	NULL
HS	NULL
IV	NULL
(	NULL
-0.2	NULL
kb	NULL
)	NULL
,	NULL
and	NULL
HS	NULL
Va	NULL
and	NULL
Vb	NULL
(	NULL
+2.8	NULL
kb	NULL
and	NULL
+3	NULL
kb	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
different	NULL
regions	NULL
of	NULL
the	NULL
locus	NULL
are	NULL
specifically	NULL
activated	NULL
when	NULL
tal-1	NULL
transcription	NULL
is	NULL
driven	NULL
from	NULL
promoters	NULL
la	NULL
and	NULL
1b	NULL
(	NULL
HS	NULL
sites	NULL
I	NULL
,	NULL
IV	NULL
and	NULL
V	NULL
)	NULL
in	NULL
erythroid/megakaryocytic	NULL
lines	NULL
(	NULL
HEL	NULL
and	NULL
K562	NULL
)	NULL
,	NULL
from	NULL
the	NULL
promoter	NULL
1b	NULL
(	NULL
HS	NULL
II	NULL
)	NULL
in	NULL
Jurkat	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
from	NULL
the	NULL
exon	NULL
4	NULL
promoter	NULL
(	NULL
HS	NULL
III	NULL
)	NULL
in	NULL
DUS28	NULL
.	NULL

Interestingly	NULL
,	NULL
HS	NULL
II	NULL
and	NULL
IH	NULL
are	NULL
also	NULL
present	NULL
,	NULL
although	NULL
to	NULL
a	NULL
much	NULL
lesser	NULL
extent	NULL
in	NULL
other	NULL
cell	NULL
lines	NULL
,	NULL
even	NULL
if	NULL
they	NULL
do	NULL
not	NULL
use	NULL
these	NULL
tal-1	NULL
promoters	NULL
.	NULL

DISCUSSION	NULL
Several	NULL
established	NULL
T-cell	NULL
lines	NULL
and	NULL
blasts	NULL
from	NULL
T-ALL	NULL
patients	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
tal-1	NULL
mRNA	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
apparent	NULL
alterations	NULL
of	NULL
tal-1	NULL
locus	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
tal-1	NULL
expression	NULL
in	NULL
T-ALL	NULL
could	NULL
result	NULL
from	NULL
an	NULL
activation	NULL
in	NULL
trams	NULL
of	NULL
both	NULL
alleles	NULL
,	NULL
possibly	NULL
reflecting	NULL
a	NULL
transitory	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
during	NULL
T-lymphocyte	NULL
differentiation	NULL
that	NULL
would	NULL
persist	NULL
on	NULL
transformation	NULL
.	NULL

Although	NULL
thymic	NULL
tal-1	NULL
transcripts	NULL
have	NULL
not	NULL
been	NULL
detected	NULL
by	NULL
Northern	NULL
blotting	NULL
analysis	NULL
,	NULL
``	NULL
``	NULL
a	NULL
transient	NULL
activation	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
particular	NULL
stages	NULL
of	NULL
T-lymphocyte	NULL
differentiation	NULL
can	NULL
not	NULL
be	NULL
formally	NULL
excluded	NULL
in	NULL
view	NULL
of	NULL
the	NULL
following	NULL
observations	NULL
:	NULL
(	NULL
1	NULL
)	NULL
a	NULL
faint	NULL
tal-1	NULL
transcription	NULL
has	NULL
been	NULL
detected	NULL
in	NULL
the	NULL
thymus	NULL
by	NULL
reverse	NULL
transcriptase	NULL
PCR	NULL
analysis	NULL
'	NULL
;	NULL
(	NULL
2	NULL
)	NULL
the	NULL
presence	NULL
of	NULL
sparse	NULL
fetal	NULL
and	NULL
adult	NULL
mouse	NULL
thymic	NULL
cells	NULL
expressing	NULL
tal-1	NULL
protein	NULL
has	NULL
been	NULL
recently	NULL
reported	NULL
``	NULL
``	NULL
;	NULL
(	NULL
3	NULL
)	NULL
a	NULL
cryptic	NULL
tal-1	NULL
promoter	NULL
located	NULL
within	NULL
exon	NULL
4	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
exclusively	NULL
active	NULL
in	NULL
leukemic	NULL
T	NULL
cells	NULL
with	NULL
or	NULL
without	NULL
tal-1	NULL
genomic	NULL
alterations	NULL
``	NULL
;	NULL
and	NULL
(	NULL
4	NULL
)	NULL
since	NULL
transcriptionally	NULL
active	NULL
loci	NULL
are	NULL
more	NULL
likely	NULL
to	NULL
be	NULL
targets	NULL
for	NULL
chromosomal	NULL
rearrangements	NULL
,	NULL
the	NULL
identification	NULL
of	NULL
recurrent	NULL
translocations	NULL
involving	NULL
tal-1	NULL
and	NULL
TCR6	NULL
loci	NULL
suggests	NULL
that	NULL
both	NULL
might	NULL
be	NULL
active	NULL
at	NULL
the	NULL
same	NULL
stage	NULL
in	NULL
early	NULL
T-cell	NULL
development	NULL
.	NULL

As	NULL
Jurkat	NULL
cell	NULL
line	NULL
is	NULL
devoid	NULL
of	NULL
gross	NULL
genomic	NULL
alterations	NULL
of	NULL
the	NULL
locus	NULL
and	NULL
expresses	NULL
a	NULL
high	NULL
level	NULL
of	NULL
tal-1	NULL
mRNA	NULL
,	NULL
initiated	NULL
mostly	NULL
in	NULL
the	NULL
exon	NULL
1b	NULL
and	NULL
to	NULL
a	NULL
much	NULL
lesser	NULL
extent	NULL
in	NULL
the	NULL
exon	NULL
4	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
both	NULL
tal-1	NULL
alleles	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
systematic	NULL
sequencing	NULL
of	NULL
tal-1-transcribed	NULL
regions	NULL
allowed	NULL
us	NULL
to	NULL
identify	NULL
a	NULL
DNA	NULL
polymorphism	NULL
in	NULL
the	NULL
coding	NULL
part	NULL
of	NULL
the	NULL
sixth	NULL
exon	NULL
.	NULL

Within	NULL
the	NULL
sensitivity	NULL
limits	NULL
of	NULL
the	NULL
method	NULL
we	NULL
used	NULL
,	NULL
our	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
tal-1	NULL
transcription	NULL
occurs	NULL
uniquely	NULL
on	NULL
one	NULL
allele	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
thus	NULL
indicating	NULL
a	NULL
cis-activating	NULL
mechanism	NULL
.	NULL

DNA	NULL
polymorphisms	NULL
such	NULL
as	NULL
the	NULL
one	NULL
reported	NULL
here	NULL
could	NULL
be	NULL
used	NULL
to	NULL
appreciate	NULL
whether	NULL
transactivation	NULL
of	NULL
the	NULL
locus	NULL
occurs	NULL
in	NULL
other	NULL
leukemic	NULL
T	NULL
cells	NULL
that	NULL
do	NULL
not	NULL
display	NULL
obvious	NULL
structural	NULL
genomic	NULL
alteration	NULL
.	NULL

The	NULL
cis-activating	NULL
mechanism	NULL
responsible	NULL
for	NULL
the	NULL
tal-1	NULL
monoallelic	NULL
transcription	NULL
in	NULL
Jurkat	NULL
could	NULL
be	NULL
either	NULL
a	NULL
point	NULL
mutation	NULL
or	NULL
a	NULL
long-range	NULL
cis-activating	NULL
rearrangement	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
investigating	NULL
this	NULL
last	NULL
hypothesis	NULL
.	NULL

To	NULL
define	NULL
the	NULL
regulatory	NULL
elements	NULL
that	NULL
control	NULL
tal-1	NULL
expression	NULL
either	NULL
in	NULL
its	NULL
germline	NULL
configuration	NULL
or	NULL
in	NULL
T-ALL	NULL
devoid	NULL
of	NULL
5	NULL
'	NULL
alteration	NULL
of	NULL
the	NULL
locus	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
investigate	NULL
tal-1	NULL
methylation	NULL
status	NULL
and	NULL
DNase-I	NULL
hypersensitivity	NULL
in	NULL
erythroid/	NULL
megakaryocytic	NULL
cell	NULL
lines	NULL
known	NULL
to	NULL
express	NULL
tal-1	NULL
from	NULL
the	NULL
promoters	NULL
1a	NULL
and	NULL
1b	NULL
,	NULL
in	NULL
Jurkat	NULL
cells	NULL
that	NULL
express	NULL
tal-1	NULL
mainly	NULL
from	NULL
the	NULL
promoter	NULL
1b	NULL
,	NULL
in	NULL
DUS28	NULL
,	NULL
a	NULL
T-cell	NULL
line	NULL
bearing	NULL
a	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
affecting	NULL
the	NULL
3	NULL
'	NULL
part	NULL
of	NULL
tal-1	NULL
transcription	NULL
unit	NULL
and	NULL
initiating	NULL
transcription	NULL
within	NULL
exon	NULL
4	NULL
,	NULL
and	NULL
in	NULL
PEER	NULL
and	NULL
HUT78	NULL
(	NULL
T-cell	NULL
lines	NULL
that	NULL
do	NULL
not	NULL
express	NULL
tal-1	NULL
gene	NULL
)	NULL
.	NULL

CpG	NULL
methylation	NULL
is	NULL
known	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
repression	NULL
of	NULL
genes	NULL
located	NULL
on	NULL
the	NULL
inactive	NULL
X	NULL
chromosome*	NULL
and	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
tissue-specific	NULL
gene	NULL
expression	NULL
.	NULL
``	NULL

''	NULL
Analysis	NULL
of	NULL
tal-1	NULL
5	NULL
'	NULL
region	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3824	NULL
1	NULL
3	NULL
wit	NULL
«	NULL
2	NULL
t	NULL
o	NULL
+3	NULL
80	NULL
4L	NULL
,	NULL
``	NULL
,	NULL
,	NULL
t	NULL
a	NULL
#	NULL
A1	NULL
6	NULL
b	NULL
B	NULL
HEL	NULL
0	NULL
A	NULL
JURKAT	NULL
0	NULL
|	NULL
23	NULL
._	NULL
K562	NULL
0	NULL
A	NULL
«	NULL
i-	NULL
20	NULL
«	NULL
11.6	NULL
«	NULL
#	NULL
7.8	NULL
<	NULL
-	NULL
4.8	NULL
<	NULL
«	NULL
<	NULL
«	NULL
#	NULL
-1.9	NULL
«	NULL
#	NULL
.	NULL

LEROY-VIARD	NULL
ET	NULL
AL	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Mapping	NULL
of	NULL
DNase-I	NULL
HS	NULL
in	NULL
the	NULL
tal-1	NULL
locus	NULL
after	NULL
Hindi	NULL
!	NULL

digestion	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Map	NULL
shows	NULL
the	NULL
germline	NULL
fragment	NULL
after	NULL
Hindll	NULL
!	NULL

(	NULL
H	NULL
)	NULL
digestion	NULL
,	NULL
the	NULL
location	NULL
of	NULL
the	NULL
Hindll	NULL
!	NULL

-Xbat	NULL
probe	NULL
(	NULL
*	NULL
)	NULL
used	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
fragments	NULL
observed	NULL
after	NULL
DNase-I	NULL
digestion	NULL
.	NULL

(	NULL
~	NULL
:	NULL
)	NULL
tai-1	NULL
first	NULL
exons	NULL
;	NULL
HS	NULL
are	NULL
depicted	NULL
by	NULL
arrows	NULL
,	NULL
and	NULL
their	NULL
location	NULL
within	NULL
tal-1	NULL
locus	NULL
is	NULL
indicated	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
tal-1	NULL
transcription	NULL
start	NULL
site	NULL
in	NULL
exon	NULL
1a	NULL
(	NULL
in	NULL
kilobases	NULL
)	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
DNA	NULL
was	NULL
extracted	NULL
from	NULL
nuclei	NULL
treated	NULL
or	NULL
not	NULL
(	NULL
0	NULL
)	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
DNase-I	NULL
,	NULL
digested	NULL
with	NULL
Hindill	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
the	NULL
probe	NULL
indicated	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Two	NULL
erythroid/mega-caryocytic	NULL
cell	NULL
lines	NULL
(	NULL
HEL	NULL
and	NULL
K562	NULL
)	NULL
,	NULL
and	NULL
four	NULL
T-cell	NULL
lines	NULL
(	NULL
JURKAT	NULL
,	NULL
DUS28	NULL
,	NULL
HUT78	NULL
,	NULL
PEER	NULL
)	NULL
were	NULL
analyzed	NULL
.	NULL

JURKAT	NULL
expresses	NULL
tal-1	NULL
gene	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
reported	NULL
genomic	NULL
alteration	NULL
of	NULL
the	NULL
locus	NULL
,	NULL
and	NULL
DUS28	NULL
expresses	NULL
tal-1	NULL
consequently	NULL
to	NULL
a	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
affecting	NULL
the	NULL
3°	NULL
noncoding	NULL
part	NULL
of	NULL
tal-1	NULL
transcription	NULL
unit	NULL
.	NULL

PEER	NULL
and	NULL
HUT78	NULL
do	NULL
not	NULL
express	NULL
this	NULL
gene	NULL
.	NULL

The	NULL
different	NULL
fragments	NULL
observed	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CHROMATIN	NULL
STRUCTURE	NULL
OF	NULL
TAL1	NULL
GENE	NULL
A	NULL
10.3	NULL
Kb	NULL
7	NULL
Kb	NULL
-3.1Kb	NULL
O	NULL
@	NULL
s	NULL
i	NULL
$	NULL
Bg	NULL
B	NULL
|	NULL
~x	NULL
da	NULL
Ib	NULL
lb	NULL
.	NULL

lla	NULL
lif	NULL
16.5	NULL
Kb	NULL
snus	NULL
.	NULL

6.1	NULL
Kb	NULL
9.4	NULL
Kb	NULL
PEER	NULL
HUT78	NULL
_	NULL
DUS28	NULL
o_	NULL
]	NULL
0	NULL
+	NULL
e	NULL
+	NULL
w	NULL
v	NULL
?	NULL

:	NULL
-a-	NULL
9.4	NULL
g	NULL
bw	NULL
go	NULL
-a-	NULL
6.1	NULL
Les	NULL
iw	NULL
c	NULL
.	NULL

<	NULL
—2.3	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
Mapping	NULL
of	NULL
DNase-l	NULL
HS	NULL
in	NULL
the	NULL
tal-1	NULL
locus	NULL
after	NULL
BamHI	NULL
digestion	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Map	NULL
shows	NULL
the	NULL
5	NULL
region	NULL
of	NULL
the	NULL
tal-1	NULL
gene	NULL
,	NULL
the	NULL
germline	NULL
fragment	NULL
after	NULL
BamHI	NULL
(	NULL
B	NULL
)	NULL
digestion	NULL
,	NULL
the	NULL
location	NULL
of	NULL
the	NULL
Bgill	NULL
(	NULL
Bg	NULL
)	NULL
-BamHI	NULL
probe	NULL
(	NULL
*	NULL
)	NULL
used	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
fragments	NULL
observed	NULL
after	NULL
DNase-I	NULL
digestion	NULL
.	NULL

(	NULL
C	NULL
)	NULL
)	NULL
tal-1	NULL
first	NULL
exons	NULL
;	NULL
HS	NULL
are	NULL
depicted	NULL
by	NULL
arrows	NULL
,	NULL
and	NULL
their	NULL
location	NULL
within	NULL
tal-1	NULL
locus	NULL
is	NULL
indicated	NULL
with	NULL
respect	NULL
to	NULL
tal1	NULL
transcription	NULL
start	NULL
site	NULL
in	NULL
exon	NULL
1a	NULL
(	NULL
in	NULL
kilobases	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNA	NULL
was	NULL
extracted	NULL
from	NULL
nuclei	NULL
treated	NULL
(	NULL
+	NULL
)	NULL
or	NULL
not	NULL
(	NULL
0	NULL
)	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
DNase-I	NULL
,	NULL
digested	NULL
with	NULL
BamHI	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
the	NULL
probe	NULL
indicated	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Two	NULL
erythroid/megakaryocytic	NULL
cell	NULL
lines	NULL
(	NULL
HEL	NULL
and	NULL
K562	NULL
)	NULL
,	NULL
and	NULL
four	NULL
T-cell	NULL
lines	NULL
(	NULL
JURKAT	NULL
,	NULL
DUS528	NULL
,	NULL
HUT78	NULL
,	NULL
PEER	NULL
)	NULL
and	NULL
a	NULL
nonhematopoietic	NULL
cell	NULL
line	NULL
(	NULL
HELA	NULL
)	NULL
were	NULL
analyzed	NULL
.	NULL

JURKAT	NULL
express	NULL
tal-1	NULL
gene	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
reported	NULL
genomic	NULL
alteration	NULL
of	NULL
the	NULL
locus	NULL
;	NULL
DUS528	NULL
bears	NULL
a	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
affecting	NULL
the	NULL
3	NULL
'	NULL
noncoding	NULL
part	NULL
of	NULL
tal-1	NULL
transcription	NULL
unit	NULL
and	NULL
express	NULL
tal-1	NULL
gene	NULL
.	NULL

PEER	NULL
and	NULL
HUT78	NULL
do	NULL
not	NULL
express	NULL
this	NULL
gene	NULL
.	NULL

The	NULL
different	NULL
fragments	NULL
observed	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

methylation	NULL
status	NULL
in	NULL
different	NULL
established	NULL
cell	NULL
lines	NULL
indicated	NULL
a	NULL
correlation	NULL
between	NULL
active	NULL
transcription	NULL
and	NULL
hypomethyla-tion	NULL
.	NULL

Yet	NULL
,	NULL
this	NULL
correlation	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
normal	NULL
tissues	NULL
that	NULL
do	NULL
not	NULL
express	NULL
the	NULL
tal-1	NULL
gene	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
tal-1	NULL
5	NULL
``	NULL
region	NULL
behaves	NULL
like	NULL
a	NULL
CpG	NULL
island	NULL
,	NULL
hypomethylated	NULL
in	NULL
normal	NULL
cells	NULL
regardless	NULL
of	NULL
tal-1	NULL
expression	NULL
,	NULL
and	NULL
methylated	NULL
de	NULL
novo	NULL
on	NULL
transcriptionally	NULL
inactive	NULL
alleles	NULL
in	NULL
established	NULL
cell	NULL
lines	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
methylation	NULL
of	NULL
CpG	NULL
islands	NULL
that	NULL
occurs	NULL
in	NULL
established	NULL
cell	NULL
lines	NULL
is	NULL
incompatible	NULL
with	NULL
expression	NULL
of	NULL
the	NULL
associated	NULL
genes	NULL
.	NULL

**	NULL
``	NULL
``	NULL
This	NULL
phenomenon	NULL
is	NULL
presumably	NULL
linked	NULL
to	NULL
the	NULL
alterations	NULL
in	NULL
chromatin	NULL
structure	NULL
and/or	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
binding	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
either	NULL
directly	NULL
or	NULL
via	NULL
competition	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
methyl	NULL
CpG	NULL
proteins	NULL
.	NULL

``	NULL
``	NULL
*	NULL
``	NULL
``	NULL
Our	NULL
data	NULL
on	NULL
the	NULL
methylation	NULL
status	NULL
of	NULL
tal-1	NULL
5	NULL
'	NULL
region	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
line	NULL
CEM	NULL
clearly	NULL
showed	NULL
a	NULL
hypomethylation	NULL
in	NULL
the	NULL
taldl	NULL
rearranged	NULL
region	NULL
(	NULL
encompassing	NULL
SIL	NULL
first	NULL
exon	NULL
and	NULL
tal-1	NULL
exon	NULL
1b	NULL
)	NULL
and	NULL
a	NULL
high	NULL
level	NULL
of	NULL
methylation	NULL
downstream	NULL
(	NULL
in	NULL
the	NULL
region	NULL
of	NULL
tal-1	NULL
exons	NULL
3825	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
even	NULL
on	NULL
the	NULL
transcriptionally	NULL
active	NULL
allele	NULL
.	NULL

This	NULL
observation	NULL
may	NULL
be	NULL
relevant	NULL
to	NULL
recent	NULL
studies	NULL
indicating	NULL
that	NULL
methylation	NULL
affects	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
preinitiation	NULL
complex	NULL
rather	NULL
than	NULL
the	NULL
elongation	NULL
of	NULL
transcription	NULL
.	NULL
``	NULL

Hypomethylation	NULL
of	NULL
Bel-2	NULL
first	NULL
exon	NULL
has	NULL
recently	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
indicative	NULL
of	NULL
trans	NULL
activation	NULL
of	NULL
both	NULL
alleles	NULL
in	NULL
B-chronic	NULL
lymphocytic	NULL
leukemias	NULL
.	NULL

*	NULL
'	NULL
The	NULL
hypomethylation	NULL
of	NULL
tal-1	NULL
gene	NULL
in	NULL
normal	NULL
T	NULL
lymphocytes	NULL
that	NULL
do	NULL
not	NULL
express	NULL
tal-1	NULL
precludes	NULL
the	NULL
utilization	NULL
of	NULL
this	NULL
chromatin	NULL
marker	NULL
to	NULL
evaluate	NULL
tal-1	NULL
monoallelic	NULL
or	NULL
biallelic	NULL
transcription	NULL
in	NULL
T-ALL	NULL
devoid	NULL
of	NULL
genomic	NULL
rearrangement	NULL
,	NULL
but	NULL
stil®	NULL
indicates	NULL
a	NULL
potential	NULL
accessibility	NULL
of	NULL
the	NULL
tal-1	NULL
locus	NULL
to	NULL
recombination	NULL
,	NULL
as	NULL
recently	NULL
reported	NULL
for	NULL
the	NULL
immunoglobulin	NULL
x	NULL
gene	NULL
segment	NULL
.	NULL
``	NULL

''	NULL
DNase-I	NULL
HS	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
cis-regulatory	NULL
sequences	NULL
and	NULL
are	NULL
usually	NULL
indicative	NULL
of	NULL
pro-tein-DNA	NULL
interactions	NULL
.	NULL
``	NULL

Extensive	NULL
mapping	NULL
of	NULL
the	NULL
DNase-I	NULL
HS	NULL
in	NULL
the	NULL
chromatin	NULL
of	NULL
several	NULL
cell	NULL
lines	NULL
allowed	NULL
us	NULL
to	NULL
identify	NULL
five	NULL
major	NULL
hypersensitive	NULL
sites	NULL
in	NULL
the	NULL
5	NULL
'	NULL
part	NULL
of	NULL
tal-1	NULL
locus	NULL
.	NULL

These	NULL
sites	NULL
were	NULL
absent	NULL
in	NULL
HELA	NULL
,	NULL
a	NULL
carcinoma-derived	NULL
cell	NULL
line	NULL
,	NULL
suggesting	NULL
their	NULL
hematopoietic	NULL
specificity	NULL
.	NULL

No	NULL
HS	NULL
was	NULL
found	NULL
in	NULL
the	NULL
3	NULL
'	NULL
part	NULL
of	NULL
the	NULL
locus	NULL
.	NULL

HS	NULL
I	NULL
is	NULL
located	NULL
10.3	NULL
kb	NULL
5	NULL
'	NULL
of	NULL
tal-1	NULL
exon	NULL
la	NULL
and	NULL
was	NULL
only	NULL
observed	NULL
in	NULL
the	NULL
erythroid/megakaryocytic	NULL
cell	NULL
lines	NULL
HEL	NULL
and	NULL
K562	NULL
.	NULL

HS	NULL
II	NULL
is	NULL
located	NULL
7	NULL
kb	NULL
5	NULL
'	NULL
of	NULL
tal-1	NULL
exon	NULL
la	NULL
,	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
fourth	NULL
tal-1	NULL
breakpoint	NULL
reported	NULL
in	NULL
SIL-tal-1	NULL
deletions	NULL
(	NULL
d4	NULL
)	NULL
.	NULL

``	NULL
*	NULL
This	NULL
HS	NULL
was	NULL
present	NULL
as	NULL
a	NULL
weak	NULL
band	NULL
in	NULL
all	NULL
the	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
tested	NULL
,	NULL
independently	NULL
of	NULL
tal-1	NULL
expression	NULL
,	NULL
but	NULL
absent	NULL
in	NULL
Hela	NULL
.	NULL

This	NULL
site	NULL
might	NULL
define	NULL
a	NULL
particular	NULL
state	NULL
of	NULL
chromatin	NULL
structure	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
tal-1	NULL
locus	NULL
that	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
competence	NULL
of	NULL
tal-1	NULL
during	NULL
hematopoie-sis	NULL
and	NULL
could	NULL
favor	NULL
recombination	NULL
events	NULL
during	NULL
T-cell	NULL
matu-ration	NULL
.	NULL

However	NULL
,	NULL
this	NULL
site	NULL
exhibited	NULL
a	NULL
strong	NULL
DNase-I	NULL
sensitivity	NULL
in	NULL
Jurkat	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
DNA	NULL
region	NULL
might	NULL
also	NULL
be	NULL
implicated	NULL
in	NULL
the	NULL
cis-activation	NULL
of	NULL
tal-1	NULL
transcription	NULL
from	NULL
103	NULL
%	NULL
+28/	NULL
+36	NULL
i	NULL
%	NULL
T	NULL
Kb	NULL
3.18	NULL
42K	NULL
?	NULL

?	NULL

?	NULL

Bo	NULL
a	NULL
?	NULL

f	NULL
8	NULL
H	NULL
B	NULL
(	NULL
8	NULL
)	NULL
Ba	NULL
M	NULL
B	NULL
L4	NULL
LLL	NULL
_	NULL
I.	NULL
LOL	NULL
*	NULL
wu	NULL
i	NULL
FU	NULL
U	NULL
la	NULL
tb	NULL
Nb	NULL
la	NULL
iM	NULL
v	NULL
§	NULL
299	NULL
)	NULL
(	NULL
olf	NULL
'-	NULL
~	NULL
v	NULL
CELL	NULL
LINE	NULL
Ks62	NULL
l	NULL
JURKAT	NULL
``	NULL
uses	NULL
Lard	NULL
®	NULL
PEER	NULL
S-	NULL
At-	NULL
t-	NULL
slie	NULL
<	NULL
-	NULL
<	NULL
--	NULL
-	NULL
HELA	NULL
*	NULL
®	NULL
Fig	NULL
5	NULL
.	NULL

Summary	NULL
of	NULL
the	NULL
DNase-l	NULL
HS	NULL
of	NULL
the	NULL
tal-1	NULL
locus	NULL
.	NULL

Diagram	NULL
shows	NULL
the	NULL
DNase-I	NULL
HS	NULL
of	NULL
the	NULL
tal-1	NULL
locus	NULL
in	NULL
erythroid/megakaryocytic	NULL
cell	NULL
lines	NULL
(	NULL
HEL	NULL
,	NULL
K562	NULL
)	NULL
and	NULL
in	NULL
T-cell	NULL
lines	NULL
(	NULL
JURKAT	NULL
,	NULL
DU528	NULL
,	NULL
HUT78	NULL
,	NULL
PEER	NULL
)	NULL
.	NULL

No	NULL
hypersensitive	NULL
site	NULL
was	NULL
found	NULL
in	NULL
a	NULL
carcinoma-derived	NULL
cell	NULL
line	NULL
(	NULL
HELA	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
regions	NULL
that	NULL
display	NULL
hypersensitivity	NULL
to	NULL
DNase-I	NULL
digestion	NULL
.	NULL

Their	NULL
location	NULL
within	NULL
tal-1	NULL
locus	NULL
is	NULL
indicated	NULL
with	NULL
respect	NULL
to	NULL
tal-1	NULL
transcription	NULL
start	NULL
site	NULL
in	NULL
exon	NULL
1a	NULL
(	NULL
in	NULL
kilobases	NULL
)	NULL
.	NULL

(	NULL
0	NULL
)	NULL
Exons	NULL
;	NULL
restriction	NULL
sites	NULL
Bgill	NULL
(	NULL
Bg	NULL
)	NULL
,	NULL
BamHI	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
HindIll	NULL
(	NULL
H	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
BamHI	NULL
site	NULL
in	NULL
brackets	NULL
indicates	NULL
a	NULL
polymorphic	NULL
site	NULL
.	NULL

The	NULL
degree	NULL
of	NULL
hypersensitivity	NULL
is	NULL
represented	NULL
by	NULL
the	NULL
boldness	NULL
of	NULL
the	NULL
arrow	NULL
;	NULL
(	NULL
-	NULL
)	NULL
site	NULL
not	NULL
observed	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3826	NULL
the	NULL
promoter	NULL
1b	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
.	NULL

This	NULL
result	NULL
,	NULL
together	NULL
with	NULL
the	NULL
monoallelic	NULL
expression	NULL
of	NULL
tal-1	NULL
in	NULL
Jurkat	NULL
,	NULL
infers	NULL
that	NULL
this	NULL
particular	NULL
region	NULL
could	NULL
mediate	NULL
the	NULL
transcriptional	NULL
effects	NULL
of	NULL
distant	NULL
DNA	NULL
rearrangements	NULL
,	NULL
as	NULL
already	NULL
reported	NULL
for	NULL
other	NULL
oncogenes	NULL
such	NULL
as	NULL
myc	NULL
or	NULL
Evil	NULL
.	NULL
``	NULL

HS	NULL
III	NULL
was	NULL
mapped	NULL
3.1	NULL
kb	NULL
5	NULL
'	NULL
of	NULL
tal-1	NULL
exon	NULL
la	NULL
.	NULL

This	NULL
site	NULL
was	NULL
major	NULL
in	NULL
DUS28	NULL
and	NULL
weak	NULL
in	NULL
HEL	NULL
and	NULL
Jurkat	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
DUS28	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
exon	NULL
4	NULL
promoter	NULL
was	NULL
supposed	NULL
to	NULL
be	NULL
driven	NULL
by	NULL
the	NULL
enhancer	NULL
of	NULL
TCR6	NULL
,	NULL
positioned	NULL
3	NULL
'	NULL
of	NULL
tal-1	NULL
transcription	NULL
unit	NULL
by	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
molecular	NULL
mechanisms	NULL
involved	NULL
in	NULL
the	NULL
deregulation	NULL
of	NULL
tal-1	NULL
gene	NULL
expression	NULL
in	NULL
DUS28	NULL
might	NULL
be	NULL
more	NULL
complex	NULL
than	NULL
previously	NULL
thought	NULL
,	NULL
since	NULL
they	NULL
might	NULL
implicate	NULL
three	NULL
different	NULL
regulatory	NULL
elements	NULL
:	NULL
the	NULL
TCR	NULL
enhancer	NULL
,	NULL
tal-1	NULL
HS	NULL
III	NULL
,	NULL
and	NULL
tal-1	NULL
exon	NULL
4	NULL
promoter	NULL
.	NULL

Such	NULL
complex	NULL
molecular	NULL
interactions	NULL
(	NULL
locus	NULL
control	NULL
region/enhancer/promoter	NULL
)	NULL
have	NULL
already	NULL
been	NULL
described	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
genes	NULL
such	NULL
as	NULL
#	NULL
globin	NULL
``	NULL
*	NULL
or	NULL
CD2	NULL
.	NULL
``	NULL

If	NULL
the	NULL
monoallelic	NULL
transcription	NULL
of	NULL
tal-1	NULL
in	NULL
Jurkat	NULL
results	NULL
from	NULL
a	NULL
long-distance	NULL
recombination	NULL
event	NULL
,	NULL
then	NULL
the	NULL
preferential	NULL
activation	NULL
of	NULL
different	NULL
HS	NULL
and	NULL
distinct	NULL
promoters	NULL
in	NULL
Jurkat	NULL
and	NULL
DUS28	NULL
should	NULL
be	NULL
linked	NULL
either	NULL
to	NULL
the	NULL
respective	NULL
location	NULL
of	NULL
the	NULL
different	NULL
regulatory	NULL
elements	NULL
on	NULL
the	NULL
rearranged	NULL
allele	NULL
,	NULL
or	NULL
to	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
regulatory	NULL
element	NULL
brought	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
tal-1	NULL
locus	NULL
by	NULL
the	NULL
rearrangement	NULL
.	NULL

HS	NULL
sites	NULL
IV	NULL
(	NULL
located	NULL
in	NULL
promoter	NULL
la	NULL
)	NULL
and	NULL
V	NULL
(	NULL
located	NULL
2.8	NULL
and	NULL
3	NULL
kb	NULL
3	NULL
'	NULL
of	NULL
tal-1	NULL
exon	NULL
1a	NULL
,	NULL
in	NULL
the	NULL
intervening	NULL
sequences	NULL
between	NULL
exons	NULL
2a	NULL
and	NULL
3	NULL
)	NULL
were	NULL
observed	NULL
exclusively	NULL
in	NULL
the	NULL
erythroid/megakaryocytic	NULL
cell	NULL
lines	NULL
.	NULL

It	NULL
should	NULL
be	NULL
pointed	NULL
out	NULL
that	NULL
HS	NULL
IV	NULL
is	NULL
located	NULL
in	NULL
the	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
tissue-specific	NULL
exon	NULL
la	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
two	NULL
GATA	NULL
motifs	NULL
and	NULL
Sp1	NULL
consensus	NULL
binding	NULL
sites	NULL
,	NULL
and	NULL
we	NULL
and	NULL
others	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
it	NULL
defines	NULL
the	NULL
tal-1	NULL
minimal	NULL
promoter	NULL
in	NULL
erythroid	NULL
cells	NULL
``	NULL
(	NULL
and	NULL
Lecointe	NULL
et	NULL
al	NULL
,	NULL
submitted	NULL
)	NULL
.	NULL

Since	NULL
this	NULL
promoter	NULL
has	NULL
a	NULL
relatively	NULL
low	NULL
activity	NULL
in	NULL
transient	NULL
assays	NULL
,	NULL
we	NULL
postulated	NULL
that	NULL
sequences	NULL
outside	NULL
of	NULL
this	NULL
region	NULL
are	NULL
likely	NULL
to	NULL
enhance	NULL
its	NULL
function	NULL
.	NULL

HS	NULL
I	NULL
and	NULL
V	NULL
might	NULL
identify	NULL
such	NULL
regions	NULL
,	NULL
since	NULL
they	NULL
were	NULL
exclusively	NULL
observed	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
erythroid/megakaryocytic	NULL
lineage	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
close	NULL
inspection	NULL
of	NULL
HS	NULL
V	NULL
sequence	NULL
shows	NULL
numerous	NULL
GATA	NULL
,	NULL
Spl	NULL
,	NULL
and	NULL
Ets	NULL
binding	NULL
sites	NULL
within	NULL
this	NULL
region	NULL
,	NULL
supporting	NULL
its	NULL
role	NULL
as	NULL
an	NULL
erythroid/megakaryocytic	NULL
regulatory	NULL
sequence	NULL
.	NULL
``	NULL

Together	NULL
,	NULL
our	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
preferential	NULL
use	NULL
of	NULL
the	NULL
different	NULL
tal-1	NULL
promoters	NULL
is	NULL
linked	NULL
to	NULL
distinct	NULL
regulatory	NULL
elements	NULL
revealed	NULL
as	NULL
strong	NULL
DNase-I	NULL
HS	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
U.	NULL
Hibner	NULL
for	NULL
critically	NULL
reviewing	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
C.	NULL
Beauchaints	NULL
and	NULL
A.M.	NULL
Dulac	NULL
for	NULL
help	NULL
in	NULL
typing	NULL
the	NULL
manuscript	NULL
and	NULL
J.M	NULL
.	NULL

Masse	NULL
for	NULL
photographs	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Begley	NULL
CG	NULL
,	NULL
Aplan	NULL
PD	NULL
,	NULL
Davey	NULL
MP	NULL
,	NULL
Nakahara	NULL
K	NULL
,	NULL
Tchorz	NULL
K	NULL
,	NULL
Kurtzberg	NULL
J	NULL
,	NULL
Hershfield	NULL
M	NULL
,	NULL
Haynes	NULL
BF	NULL
,	NULL
Cohen	NULL
DI	NULL
,	NULL
Waldmann	NULL
TA	NULL
,	NULL
Kirsch	NULL
IR	NULL
:	NULL
Chromosomal	NULL
translocation	NULL
in	NULL
a	NULL
human	NULL
leukemic	NULL
stem-cell	NULL
line	NULL
disrupts	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
6-chain	NULL
diversity	NULL
region	NULL
and	NULL
results	NULL
in	NULL
a	NULL
previously	NULL
unreported	NULL
fusion	NULL
transcript	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:2031	NULL
,	NULL
1989	NULL
2	NULL
.	NULL

Finger	NULL
LR	NULL
,	NULL
Kagan	NULL
J	NULL
,	NULL
Christopher	NULL
G	NULL
,	NULL
Kurtzberg	NULL
J	NULL
,	NULL
Hershfield	NULL
MS	NULL
,	NULL
Nowell	NULL
PC	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
Involvement	NULL
of	NULL
the	NULL
TCLS5	NULL
gene	NULL
on	NULL
LEROY-VIARD	NULL
ET	NULL
AL	NULL
human	NULL
chromosome	NULL
1	NULL
in	NULL
T-cell	NULL
leukemia	NULL
and	NULL
melanoma	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:5039	NULL
,	NULL
1989	NULL
3	NULL
.	NULL

Chen	NULL
Q	NULL
,	NULL
Cheng	NULL
J-T	NULL
,	NULL
Tsai	NULL
L-H	NULL
,	NULL
Schneider	NULL
N	NULL
,	NULL
Buchanan	NULL
G	NULL
,	NULL
Caroll	NULL
A	NULL
,	NULL
Crist	NULL
W	NULL
,	NULL
Ozanne	NULL
B	NULL
,	NULL
Siciliano	NULL
MJ	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
The	NULL
tal	NULL
gene	NULL
undergoes	NULL
chromosome	NULL
translocation	NULL
in	NULL
T	NULL
cell	NULL
leukemia	NULL
and	NULL
potentially	NULL
encodes	NULL
a	NULL
helix-loop-helix	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
9:415	NULL
,	NULL
1990	NULL
4	NULL
.	NULL

Visvader	NULL
J	NULL
,	NULL
Begley	NULL
CG	NULL
:	NULL
Helix-loop-helix	NULL
genes	NULL
translocated	NULL
in	NULL
lymphoid	NULL
leukemia	NULL
.	NULL

TIBS	NULL
16:330	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Murre	NULL
C	NULL
,	NULL
Caw	NULL
M	NULL
,	NULL
Schonleber	NULL
P	NULL
,	NULL
Vaessin	NULL
H	NULL
,	NULL
Caudy	NULL
M	NULL
,	NULL
Jan	NULL
LY	NULL
,	NULL
Jan	NULL
YN	NULL
,	NULL
Cabrera	NULL
CV	NULL
,	NULL
Buskin	NULL
JN	NULL
,	NULL
Hauschka	NULL
SD	NULL
,	NULL
Lassar	NULL
AB	NULL
,	NULL
Weintraub	NULL
H	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
,	NULL
MyoD	NULL
,	NULL
and	NULL
myc	NULL
proteins	NULL
.	NULL

Cell	NULL
56:777	NULL
,	NULL
1989	NULL
6	NULL
.	NULL

Green	NULL
AR	NULL
,	NULL
Lints	NULL
T	NULL
,	NULL
Visvader	NULL
J	NULL
,	NULL
Harvey	NULL
R	NULL
,	NULL
Begley	NULL
CG	NULL
:	NULL
SCL	NULL
is	NULL
coexpressed	NULL
with	NULL
GATA-1	NULL
in	NULL
hemopoietic	NULL
cells	NULL
but	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
developing	NULL
brain	NULL
.	NULL

Oncogene	NULL
7:653	NULL
,	NULL
1992	NULL
7	NULL
.	NULL

Mouthon	NULL
MA	NULL
,	NULL
Bernard	NULL
O	NULL
,	NULL
Mitjavila	NULL
MT	NULL
,	NULL
Romeo	NULL
PH	NULL
,	NULL
Vain-chenker	NULL
W	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
:	NULL
Expression	NULL
of	NULL
tal-1	NULL
and	NULL
GATA-bind-ing	NULL
proteins	NULL
during	NULL
human	NULL
hematopoiesis	NULL
.	NULL

Blood	NULL
81:647	NULL
,	NULL
1993	NULL
8	NULL
.	NULL

Bash	NULL
RO	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Shuster	NULL
JJ	NULL
,	NULL
Link	NULL
MP	NULL
,	NULL
Amylon	NULL
M	NULL
,	NULL
Pullen	NULL
J	NULL
,	NULL
Carroll	NULL
AJ	NULL
,	NULL
Buchanan	NULL
GR	NULL
,	NULL
Smith	NULL
GR	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Clinical	NULL
features	NULL
and	NULL
outcome	NULL
of	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
in	NULL
childhood	NULL
with	NULL
respect	NULL
to	NULL
alterations	NULL
at	NULL
the	NULL
TAL1	NULL
locus	NULL
:	NULL
A	NULL
Pediatric	NULL
Oncology	NULL
Group	NULL
study	NULL
.	NULL

Blood	NULL
81:2110	NULL
,	NULL
1993	NULL
9	NULL
.	NULL

Janssen	NULL
JWG	NULL
,	NULL
Ludwig	NULL
WD	NULL
,	NULL
Sterry	NULL
W	NULL
,	NULL
Bartram	NULL
CR	NULL
:	NULL
SIL-TAL1	NULL
deletion	NULL
in	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Leukemia	NULL
7:1204	NULL
,	NULL
1993	NULL
10	NULL
.	NULL

Kikuchi	NULL
A	NULL
,	NULL
Hayashi	NULL
Y	NULL
,	NULL
Kobayashi	NULL
S	NULL
,	NULL
Hanada	NULL
R	NULL
,	NULL
Moriwaki	NULL
K	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Fujimoto	NULL
JI	NULL
,	NULL
Kaneko	NULL
Y	NULL
,	NULL
Yamamori	NULL
S	NULL
:	NULL
Clinical	NULL
significance	NULL
of	NULL
TAL1	NULL
gene	NULL
alteration	NULL
in	NULL
childhood	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
.	NULL

Leukemia	NULL
7:933	NULL
,	NULL
1993	NULL
11	NULL
.	NULL

Aplan	NULL
PD	NULL
,	NULL
Lombardi	NULL
DP	NULL
,	NULL
Reaman	NULL
GH	NULL
,	NULL
Sather	NULL
HN	NULL
,	NULL
Hammond	NULL
GD	NULL
,	NULL
Kirsch	NULL
IR	NULL
:	NULL
Involvement	NULL
of	NULL
the	NULL
putative	NULL
hematopoietic	NULL
transcription	NULL
factor	NULL
SCL	NULL
in	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Blood	NULL
79:1327	NULL
,	NULL
1992	NULL
12	NULL
.	NULL

Bernard	NULL
O	NULL
,	NULL
Lecointe	NULL
N	NULL
,	NULL
Jonveaux	NULL
P	NULL
,	NULL
Souyri	NULL
M	NULL
,	NULL
Mauchauffé	NULL
M	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Larsen	NULL
CJ	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
:	NULL
Two	NULL
site-specific	NULL
deletions	NULL
and	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
restricted	NULL
to	NULL
haman	NULL
T-cell	NULL
acute	NULL
leukemias	NULL
disrupt	NULL
the	NULL
5	NULL
'	NULL
part	NULL
of	NULL
the	NULL
tal-/	NULL
gene	NULL
.	NULL

Oncogene	NULL
6:1477	NULL
,	NULL
1991	NULL
13	NULL
.	NULL

Bernard	NULL
O	NULL
,	NULL
Barin	NULL
C	NULL
,	NULL
Charrin	NULL
C	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
,	NULL
Berger	NULL
R	NULL
:	NULL
Characterization	NULL
of	NULL
translocation	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p32	NULL
;	NULL
q11	NULL
)	NULL
in	NULL
a	NULL
T	NULL
and	NULL
in	NULL
a	NULL
B	NULL
acute	NULL
leukemia	NULL
.	NULL

Leukemia	NULL
7:1509	NULL
,	NULL
1993	NULL
14	NULL
.	NULL

Breit	NULL
TM	NULL
,	NULL
Mol	NULL
EJ	NULL
,	NULL
Wolvers-Tettero	NULL
ILM	NULL
,	NULL
Ludwig	NULL
WD	NULL
,	NULL
van	NULL
Wering	NULL
ER	NULL
,	NULL
van	NULL
Dongen	NULL
JJM	NULL
:	NULL
Site-specific	NULL
deletions	NULL
involving	NULL
the	NULL
tal-1	NULL
and	NULL
sil	NULL
genes	NULL
are	NULL
restricted	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
a/f	NULL
lineage	NULL
:	NULL
T	NULL
cell	NULL
receptor	NULL
8	NULL
gene	NULL
deletion	NULL
mechanism	NULL
affects	NULL
multiple	NULL
genes	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
177:965	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Brown	NULL
L	NULL
,	NULL
Cheng	NULL
JT	NULL
,	NULL
Chen	NULL
Q	NULL
,	NULL
Siciliano	NULL
MJ	NULL
,	NULL
Crist	NULL
W	NULL
,	NULL
Buchanan	NULL
G	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Site-specific	NULL
recombination	NULL
of	NULL
the	NULL
ral-1	NULL
gene	NULL
is	NULL
a	NULL
common	NULL
occurrence	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

EMBO	NULL
J	NULL
9:3343	NULL
,	NULL
1990	NULL
16	NULL
.	NULL

Carroll	NULL
AJ	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Link	NULL
MP	NULL
,	NULL
Amylon	NULL
MD	NULL
,	NULL
Pullen	NULL
J	NULL
,	NULL
Ragab	NULL
AH	NULL
,	NULL
Buchanan	NULL
GR	NULL
,	NULL
Wimmer	NULL
RS	NULL
,	NULL
Viet	NULL
TJ	NULL
;	NULL
The	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p34	NULL
;	NULL
q11	NULL
)	NULL
is	NULL
nonrandom	NULL
and	NULL
restricted	NULL
to	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
:	NULL
A	NULL
Pediatric	NULL
Oncology	NULL
Group	NULL
study	NULL
.	NULL

Blood	NULL
76:1220	NULL
,	NULL
1990	NULL
17	NULL
.	NULL

Bernard	NULL
O	NULL
,	NULL
Guglielmi	NULL
P	NULL
,	NULL
Jonveaux	NULL
P	NULL
,	NULL
Cherif	NULL
D	NULL
,	NULL
Gisselbrecht	NULL
S	NULL
$	NULL
,	NULL
Mauchauffe	NULL
M	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Larsen	NULL
CJ	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
:	NULL
Two	NULL
distinct	NULL
mechanisms	NULL
for	NULL
the	NULL
SCL	NULL
gene	NULL
activation	NULL
in	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
of	NULL
T-cell	NULL
leukemias	NULL
.	NULL

Genes	NULL
Chrom	NULL
Cancer	NULL
1:194	NULL
,	NULL
1990	NULL
18	NULL
.	NULL

Aplan	NULL
PD	NULL
,	NULL
Raimondi	NULL
SC	NULL
,	NULL
Kirsch	NULL
IR	NULL
:	NULL
Disruption	NULL
of	NULL
the	NULL
SCL	NULL
gene	NULL
by	NULL
a	NULL
t	NULL
(	NULL
1	NULL
;	NULL
3	NULL
)	NULL
translocation	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
T	NULL
cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
176:1303	NULL
,	NULL
1992	NULL
19	NULL
.	NULL

Bernard	NULL
O	NULL
,	NULL
Azogui	NULL
O	NULL
,	NULL
Lecointe	NULL
N	NULL
,	NULL
Mugneret	NULL
F	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

CHROMATIN	NULL
STRUCTURE	NULL
OF	NULL
TAL1	NULL
GENE	NULL
Larsen	NULL
CJ	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
:	NULL
A	NULL
third	NULL
ta/-1	NULL
promoter	NULL
is	NULL
specifically	NULL
used	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukemias	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
176:919	NULL
,	NULL
1992	NULL
20	NULL
.	NULL

Xia	NULL
Y	NULL
,	NULL
Brown	NULL
L	NULL
,	NULL
Tsou	NULL
Tsan	NULL
J	NULL
,	NULL
Ying-Chuan	NULL
Yang	NULL
C	NULL
,	NULL
Sicillano	NULL
MJ	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Carroll	NULL
AJ	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
The	NULL
translocation	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p34	NULL
;	NULL
q11	NULL
)	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
:	NULL
Chromosome	NULL
breakage	NULL
25	NULL
kilo-base	NULL
pairs	NULL
downstream	NULL
of	NULL
the	NULL
TALI	NULL
protooncogene	NULL
.	NULL

Genes	NULL
Chrom	NULL
Cancer	NULL
4:211	NULL
,	NULL
1992	NULL
21	NULL
.	NULL

Fitzgerald	NULL
TJ	NULL
,	NULL
Neale	NULL
GAM	NULL
,	NULL
Raimondi	NULL
SC	NULL
,	NULL
Goorha	NULL
RM	NULL
:	NULL
c-tal	NULL
,	NULL
a	NULL
helix-loop-helix	NULL
protein	NULL
,	NULL
is	NULL
juxtaposed	NULL
to	NULL
the	NULL
T-cell	NULL
re-ceptor-	NULL
#	NULL
chain	NULL
gene	NULL
by	NULL
a	NULL
reciprocal	NULL
chromosomal	NULL
translocation	NULL
:	NULL
t	NULL
(	NULL
1	NULL
;	NULL
7	NULL
)	NULL
(	NULL
p32	NULL
;	NULL
q35	NULL
)	NULL
.	NULL

Blood	NULL
78:2686	NULL
,	NULL
1991	NULL
22	NULL
.	NULL

Macintyre	NULL
EA	NULL
,	NULL
Smit	NULL
L	NULL
,	NULL
Ritz	NULL
J	NULL
,	NULL
Kirsch	NULL
IR	NULL
,	NULL
Strominger	NULL
JL	NULL
:	NULL
Disruption	NULL
of	NULL
the	NULL
SCL	NULL
locus	NULL
in	NULL
T-lymphoid	NULL
malignancies	NULL
correlates	NULL
with	NULL
commitment	NULL
to	NULL
the	NULL
T-cell	NULL
receptor	NULL
alpha/beta	NULL
lineage	NULL
.	NULL

Blood	NULL
80:1511	NULL
,	NULL
1992	NULL
23	NULL
.	NULL

Aplan	NULL
PD	NULL
,	NULL
Begley	NULL
CG	NULL
,	NULL
Bertness	NULL
V	NULL
,	NULL
Nussmeier	NULL
M	NULL
,	NULL
Ezquerra	NULL
A	NULL
,	NULL
Coligan	NULL
J	NULL
,	NULL
Kirsch	NULL
IR	NULL
:	NULL
The	NULL
SCL	NULL
gene	NULL
is	NULL
formed	NULL
from	NULL
a	NULL
transcriptionally	NULL
complex	NULL
locus	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:6426	NULL
,	NULL
1990	NULL
24	NULL
.	NULL

Bird	NULL
A	NULL
:	NULL
The	NULL
essentials	NULL
of	NULL
DNA	NULL
methylation	NULL
.	NULL

Cell	NULL
70:5	NULL
,	NULL
1992	NULL
25	NULL
.	NULL

Cedar	NULL
H	NULL
:	NULL
DNA	NULL
methylation	NULL
and	NULL
gene	NULL
activity	NULL
.	NULL

Cell	NULL
53:3	NULL
,	NULL
1988	NULL
26	NULL
.	NULL

Bonifer	NULL
C	NULL
,	NULL
Vidal	NULL
M	NULL
,	NULL
Grosveld	NULL
F	NULL
,	NULL
Sippel	NULL
AE	NULL
:	NULL
Tissue	NULL
specific	NULL
and	NULL
position	NULL
independent	NULL
expression	NULL
of	NULL
the	NULL
complete	NULL
gene	NULL
domain	NULL
for	NULL
chicken	NULL
lysozyme	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

EMBO	NULL
J	NULL
9:2843	NULL
,	NULL
1990	NULL
27	NULL
.	NULL

Greaves	NULL
DR	NULL
,	NULL
Wilson	NULL
FD	NULL
,	NULL
Lang	NULL
G	NULL
,	NULL
Kioussis	NULL
D	NULL
:	NULL
Human	NULL
CD2	NULL
3'-flanking	NULL
sequences	NULL
confer	NULL
high-level	NULL
,	NULL
T	NULL
cell-specific	NULL
,	NULL
position-independent	NULL
gene	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Cell	NULL
56:979	NULL
,	NULL
1989	NULL
28	NULL
.	NULL

Grosveld	NULL
F	NULL
,	NULL
Blom	NULL
van	NULL
Assendelft	NULL
G	NULL
,	NULL
Greaves	NULL
DR	NULL
,	NULL
Kollias	NULL
G	NULL
:	NULL
Position-independent	NULL
,	NULL
high	NULL
level	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
beta-glo-bin	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Cell	NULL
51:975	NULL
,	NULL
1987	NULL
29	NULL
.	NULL

Spanopoulou	NULL
E	NULL
,	NULL
Giguere	NULL
V	NULL
,	NULL
Grosveld	NULL
F	NULL
:	NULL
Transcriptional	NULL
unit	NULL
of	NULL
the	NULL
murine	NULL
Thy-1	NULL
gene	NULL
:	NULL
Different	NULL
distribution	NULL
of	NULL
transcription	NULL
initiation	NULL
sites	NULL
in	NULL
brain	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
8:3847	NULL
,	NULL
1988	NULL
30	NULL
.	NULL

Begley	NULL
CG	NULL
,	NULL
Aplan	NULL
PD	NULL
,	NULL
Denning	NULL
SM	NULL
,	NULL
Haynes	NULL
BF	NULL
,	NULL
Waldmann	NULL
TA	NULL
,	NULL
Kirsch	NULL
IR	NULL
:	NULL
The	NULL
gene	NULL
SCL	NULL
is	NULL
expressed	NULL
during	NULL
early	NULL
hematopoie-sis	NULL
and	NULL
encodes	NULL
a	NULL
differentiation-related	NULL
DNA-binding	NULL
motif	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:10128	NULL
,	NULL
1989	NULL
31	NULL
.	NULL

Visvader	NULL
J	NULL
,	NULL
Begley	NULL
CG	NULL
,	NULL
Adams	NULL
JM	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
the	NULL
LYL	NULL
,	NULL
SCL	NULL
and	NULL
E2A	NULL
helix-loop-helix	NULL
genes	NULL
within	NULL
the	NULL
hemopoietic	NULL
system	NULL
.	NULL

Oncogene	NULL
6:187	NULL
,	NULL
1991	NULL
32	NULL
.	NULL

Kallianpur	NULL
AR	NULL
,	NULL
Jordan	NULL
JE	NULL
,	NULL
Brandt	NULL
SJ	NULL
:	NULL
;	NULL
The	NULL
SCL/TAL-1	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
progenitors	NULL
of	NULL
both	NULL
the	NULL
hematopoietic	NULL
and	NULL
vascular	NULL
systems	NULL
during	NULL
embryogenesis	NULL
.	NULL

Blood	NULL
83:1200	NULL
,	NULL
1994	NULL
33	NULL
.	NULL

Riggs	NULL
AD	NULL
,	NULL
Pfeifer	NULL
GP	NULL
:	NULL
X-chromosome	NULL
inactivation	NULL
and	NULL
cell	NULL
memory	NULL
.	NULL

TIG	NULL
8:169	NULL
,	NULL
1992	NULL
34	NULL
.	NULL

Antequera	NULL
F	NULL
,	NULL
Boyes	NULL
J	NULL
,	NULL
Bird	NULL
A	NULL
:	NULL
High	NULL
levels	NULL
of	NULL
de	NULL
novo	NULL
methyl	NULL
3827	NULL
ation	NULL
and	NULL
altered	NULL
chromatin	NULL
structure	NULL
at	NULL
CpG	NULL
islands	NULL
in	NULL
cell	NULL
lines	NULL
.	NULL

Cell	NULL
62:503	NULL
,	NULL
1990	NULL
35	NULL
.	NULL

Sneller	NULL
MC	NULL
,	NULL
Gunter	NULL
KC	NULL
:	NULL
DNA	NULL
methylation	NULL
alters	NULL
chromatin	NULL
structure	NULL
and	NULL
regulates	NULL
Thy-1	NULL
expression	NULL
in	NULL
EL-4	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
138:3505	NULL
,	NULL
1987	NULL
36	NULL
.	NULL

Boyes	NULL
J	NULL
,	NULL
Bird	NULL
A	NULL
:	NULL
Repression	NULL
of	NULL
genes	NULL
by	NULL
DNA	NULL
methylation	NULL
depends	NULL
on	NULL
CpG	NULL
density	NULL
and	NULL
promoter	NULL
strength	NULL
:	NULL
Evidence	NULL
for	NULL
involvement	NULL
of	NULL
a	NULL
methyl-CpG	NULL
binding	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
11:327	NULL
,	NULL
1992	NULL
37	NULL
.	NULL

Keshet	NULL
I	NULL
,	NULL
Lieman	NULL
Hurwitz	NULL
J	NULL
,	NULL
Cedar	NULL
H	NULL
:	NULL
DNA	NULL
methylation	NULL
affects	NULL
the	NULL
formation	NULL
of	NULL
active	NULL
chromatin	NULL
.	NULL

Cell	NULL
44:535	NULL
,	NULL
1986	NULL
38	NULL
.	NULL

Watt	NULL
F	NULL
,	NULL
Molloy	NULL
PL	NULL
:	NULL
Cytosine	NULL
methylation	NULL
prevents	NULL
binding	NULL
to	NULL
DNA	NULL
of	NULL
a	NULL
HeLa	NULL
cell	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
optimal	NULL
expression	NULL
of	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
.	NULL

Genes	NULL
Dev	NULL
2:1136	NULL
,	NULL
1988	NULL
39	NULL
.	NULL

Lewis	NULL
JD	NULL
,	NULL
Mechan	NULL
RR	NULL
,	NULL
Henzel	NULL
WJ	NULL
,	NULL
Maurer-Fogy	NULL
I	NULL
,	NULL
Jeppesen	NULL
P	NULL
,	NULL
Klein	NULL
F	NULL
,	NULL
Bird	NULL
A	NULL
:	NULL
Purification	NULL
,	NULL
sequence	NULL
,	NULL
and	NULL
cellular	NULL
localization	NULL
of	NULL
a	NULL
novel	NULL
chromosomal	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
methylated	NULL
DNA	NULL
.	NULL

Cell	NULL
69:905	NULL
,	NULL
1992	NULL
40	NULL
.	NULL

Levine	NULL
A	NULL
,	NULL
Cantoni	NULL
GL	NULL
,	NULL
Razin	NULL
A	NULL
:	NULL
Methylation	NULL
in	NULL
the	NULL
preinitiation	NULL
domain	NULL
suppresses	NULL
gene	NULL
transcription	NULL
by	NULL
an	NULL
indirect	NULL
mechanism	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:10119	NULL
,	NULL
1992	NULL
41	NULL
.	NULL

Hanada	NULL
M	NULL
,	NULL
Delia	NULL
D	NULL
,	NULL
Aiello	NULL
A	NULL
,	NULL
Stadtmauer	NULL
E	NULL
,	NULL
Reed	NULL
JC	NULL
:	NULL
bei-2	NULL
gene	NULL
hypomethylation	NULL
and	NULL
high-level	NULL
expression	NULL
in	NULL
B-cell	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
.	NULL

Blood	NULL
82:1820	NULL
,	NULL
1993	NULL
42	NULL
.	NULL

Goodhardt	NULL
M	NULL
,	NULL
Cavelier	NULL
P	NULL
,	NULL
Doyen	NULL
N	NULL
,	NULL
Kallenbach	NULL
S	NULL
,	NULL
Babinet	NULL
C	NULL
,	NULL
Rougeon	NULL
F	NULL
:	NULL
Methylation	NULL
status	NULL
of	NULL
immunoglobulin	NULL
x	NULL
gene	NULL
segments	NULL
correlates	NULL
with	NULL
their	NULL
recombination	NULL
potential	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
23:1789	NULL
,	NULL
1993	NULL
43	NULL
.	NULL

Hsich	NULL
CL	NULL
,	NULL
Lieber	NULL
MR	NULL
:	NULL
CpG	NULL
methylated	NULL
minichromosomes	NULL
become	NULL
inaccessible	NULL
for	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
after	NULL
undergoing	NULL
repli-cation	NULL
.	NULL

EMBO	NULL
J	NULL
11:315	NULL
,	NULL
1992	NULL
44	NULL
.	NULL

Gross	NULL
DS	NULL
:	NULL
Nuclease	NULL
hypersensitive	NULL
sites	NULL
in	NULL
chromatin	NULL
.	NULL

Annu	NULL
Rev	NULL
Biochem	NULL
57:159	NULL
,	NULL
1988	NULL
45	NULL
.	NULL

Lazo	NULL
PA	NULL
,	NULL
Lee	NULL
JS	NULL
,	NULL
Tsichlis	NULL
PN	NULL
:	NULL
Long-distance	NULL
activation	NULL
of	NULL
the	NULL
mye	NULL
protooncogene	NULL
by	NULL
provirus	NULL
insertion	NULL
in	NULL
Mivi-1	NULL
or	NULL
Mivi-4	NULL
in	NULL
rat	NULL
T-cell	NULL
lymphomas	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:170	NULL
,	NULL
1990	NULL
46	NULL
.	NULL

Bartholomew	NULL
C	NULL
,	NULL
Ihle	NULL
JN	NULL
:	NULL
Retroviral	NULL
insertions	NULL
90	NULL
kilobases	NULL
proximal	NULL
to	NULL
the	NULL
Evi-1	NULL
myeloid	NULL
transforming	NULL
gene	NULL
activate	NULL
transcription	NULL
from	NULL
the	NULL
normal	NULL
promoter	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:1820	NULL
,	NULL
1991	NULL
47	NULL
.	NULL

Aplan	NULL
PD	NULL
,	NULL
Nakahara	NULL
K	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Kirsh	NULL
IR	NULL
:	NULL
The	NULL
SCL	NULL
gene	NULL
product	NULL
:	NULL
A	NULL
positive	NULL
regulator	NULL
of	NULL
erythroid	NULL
differentiation	NULL
.	NULL

EMBO	NULL
J	NULL
11:4073	NULL
,	NULL
1992	NULL
48	NULL
.	NULL

Raich	NULL
N	NULL
,	NULL
Romeo	NULL
PH	NULL
:	NULL
Erythroid	NULL
regulatory	NULL
elements	NULL
.	NULL

Stem	NULL
Cells	NULL
11:95	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1994	NULL
84	NULL
:	NULL
3819-3827	NULL
Distinct	NULL
DNase-I	NULL
hypersensitive	NULL
sites	NULL
are	NULL
associated	NULL
with	NULL
TAL-1	NULL
transcription	NULL
in	NULL
erythroid	NULL
and	NULL
T-cell	NULL
lines	NULL
K	NULL
Leroy-Viard	NULL
,	NULL
MA	NULL
Vinit	NULL
,	NULL
N	NULL
Lecointe	NULL
,	NULL
D	NULL
Mathieu-Mahul	NULL
and	NULL
PH	NULL
Romeo	NULL
4	NULL
,	NULL
8	NULL
5	NULL
p	NULL
'	NULL
ﬁ	NULL
'	NULL
f	NULL
)	NULL
..	NULL
os	NULL
2101	NULL
%	NULL
N	NULL
@	NULL
0	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/84/11/3819.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

